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Bulatao  and Stephens  report  estimates  and  birth in developing  countries  is projected  to rise
projections  of deaths  by cause  for major  world  by five years.
regions,  based on data from country  reports  to
the World  Healt, Organization  and regression  * The leading  causes of death for the world  as
models.  They report  mortality  rates for seven  a whole for both 1970  and 1985  were infectious
major  causes: infectious  and parasitic  diseases,  and parasitic  diseases  and circulatory  system
neoplasms,  circulatory  system  diseases,  compli-  diseases  - with the first more important  in
cations of pregnancy,  certain  perinatal  condi-  developing  countries,  and the second  more
tions, injury  and poisoning,  and other  causes.  important  in developed  countries.  Certain
Some more  specific causes are reported  on. They  perinatal  conditions  were also more important
give estimates  for six age groups  by sex for four  for developing  countries,  but accounted  for only
years (1970, 1985,  2000, and 2015) and six  a fourth  or a fifth  as many  deaths in 1985.
country  groups:  industrial  market  economies,  Neoplasms  were more important  in developed
industrial  nonmarket  economies,  Latin America  than in developing  countries.
and the Caribbean,  Sub-Saharan  Africa,  the
Middle East and North Africa,  and Asia and the  * Deaths from infectious  diseases  are ex-
Pacific.  pected to decline  as a percentage  of deaths;
proportionate  deaths from diseases  of the circula-
Among  their findings:  tory system  are expected  to rise.
* The populadon  over 45 in developing  * The greatest  number  of deaths  will continue
countries  is projected  to more than  double  to be in Asia, where almost  half of all deaths  in
between 1985  and 2015, rising from 17 to 24  the world  take place. This proportion  is not
percent of the population.  Causes  of death,  projected  to change.
which are closely  related  to age at death,  must
change accordingly.  *  Better  data on causes of death are essential.
The World  Health  Organization  is working  with
* Infant  mortality  in developing  countries  is  countries  to strengthen  their cause-of-death
projected  to fall from 78 per thousand  in 1985  to  information  systems  as an essential  support  for
43 per thousand  in 2015 and life expectancy  at  health  monitoring.
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IVEstimates and projections of deaths by  cause for major world regions are
reported here. The sources for these estimates are country reports to the World Health
Organization (WHO)  and regression models.
Mortality  rates will be reported for seven major causes-infectious and parasitic
diseases, neoplasms, circulattty system diseawes,  complications  of pregnancy, certain
perinatal conditions,  injurv  and poisoning, and other causes-and  for more specific
causes under some headings. For the major causes, predictive equations depending on
the overall mortality level were previously estimated to supplement reported data; for
the specific  causes, WHO data and some new equations will be the basis.
Estimates were made for six age groups (0, 1-4, 5-14, 15-44, 45-64, and 65 and
older) by sex for four years (1970,  1985, 2000, and 2015) and six country groups-
industrial market economies, industial  nonmarket economies, Lafin America and the
Caribbean  (LAC),  Sub-Saharan  Afica, the Middle East and North Africa (IMENA),  and
Asia and the Pacific.  Clsfication  of countries as industral  or developing (Annex A)
is as of 1985.
The objective, approach, and background of the exercise are discussed; the
methodology is described; current and projected distrbutions of death by cause are
presented and contrasted  among regions; and the reasonableness of and possible  biases
in the estimates are assessed.
Background
The main objective  of this exercise  is to provide a comprehensive picture of the
dsriution  of deaths by underlying cause for 1985  and a gerneral  perspective on how
the distribution can be expected to change. We attempt to classify current deaths by
both maor and specific  cause, but project only the major causes into the future.
The  approach  is to  summarize reports  of  causes of  death  to  WHO  and
supplement these with regression estimates  for nonreporting countries. An alternative
would have been to consider diseases or disease groups one by one, building up  a
composite  picture from the epidemiologicalliterature.  Though disease  experts  have been
canvassed for information  on this literature, we do not rely primarily  on this approach
because it would lead to inconsistencies  between estimates for different diseases and
would provide overaU  mortality rates at odds with other mortality data.
The approach taken follows work initiated by Preston (1976)  and continued by
Hakulinen and others (1986a,  1986b),  whose age-sex  specific  equations for major causes
of death are used  here.  This regression-based approach has also been  applied to
partcular areas, such as cancer deaths (Parkdn  and others 1988).
Hakulinen and others estimated the distrbution of deaths by major cause as of
1980.  We update their estimates to 1985,  incorporate new data not available to them,
attempt a more detailed clasification of causes, and provide perspectives on possible
future trends.2  Estimates  and  PAijections  of Mortality  by Cause
Method
This section covers categories  of causes of death; the nature and quality of the
base data; the estimation and projection  of mortality; the equations used to disaggregate
mortality by major cause; and procedur; - for subdividing major causes into specific
categories.
Grouping  causes of death
The categories  for major causes of death shown in Table 1 are identical to those
used  by  Hakulinen and  others to permit the application of their equations. These
categories  require some explanation. Bronchitis,  emphysema, and asthma are included
among the  infectious and  parasitic diseases because  of  the  important  infectious
bronchitis component, which was not separable  from the others because of the way the
Table  1. Classificatlon  of causes of death  and  corresponding  International  Classificatlon  of
Diseases,  Injuries,  and  Causes of Death (lCD) categories
ICD-9 (Basic
Causi.  of death  category  ICD-8  (List  A)  tabulation  list)
Major  CAUses
1  Infectious  and parasitic  diseases  A1-44, A99,  A90-93  01-07,  320-323
2  Neoplasms  A45-61  08-17
3  Circulatory  system and certain degenerative  A80-88,  A64,  A98,  A102, 25-30, 181,  341,
diseases  A105-106  347, 350
4  Complications  of pregnancy  A112-118  38-39, 41
5  Perinatal  conditions  A131-135  45
6  Injury and poisoning  AE138-150  E47-E56
7  Other causes  Other codes  Other codes
Specfc causes
1.1  Diarrhea  Al-5  01
1.2  Tuberculosis  A6-10  02
1.3  Acute respiratory  infection  A15-17,  A89-92  033-035,  320-322
1.4  Measles  A25  042
1.5  Chronic obstructive  pulmonary  disease (COPD)  A93  323-325
1.6  Polio  A22-23  040, 078
1.7  Yellow  fever, dengue, and encephalitis  A26-27  044-045
1.8  Malaria  A31  052
1.9  Schistosomiasis  and filariasis  A39,  A41  072, 074
1.10 Intestinal parasltes  A42-43  075076
3.1  Ischernc heart disease  A83  27
3.2  Cerebrovascular  disease  A85  29
3.3  Other cardiovascular  diseases  A80,  A82,  A84,  A86-88  25, 26, 28, 30
3.4  Diabetes  A64  181
3.5  Certain degenerative  diseases (nephrltis,  cirrhosis  of  A98,  A102,  A105,  A106  341,347,  350
the liver, ulcers of the stomach  and duodenum)
7.1  Mental disorders  A69  210-  -212
7.2  Oral health diseases  A97  330
7.3  Mlcronutrient  disorders  A62-63,  A67  180,  193, 200
7.4  Malnutrition  A65  190-192
Note: The specific  diseases  listed under infectious  and parasitic diseases  (1.1-1.10)  and under other
causes (7.1-7.4)  are not meant to be comprehensive.Mdhad  3
data were reported. Diabetes,  nephritis, cirrhosis of the liver, and ulcers of the stomach
and duodenum have been included among circulatory  system diseases not because of
any  presumed  simaty  in  etiology or pathogenesis but  to  keep  the  number  of
categories  manageable by combining  the degenerative diseases other than cancer.
Hakulinen and others  also included in  their analysis two subcategories for
infectious and  parasitic diseases: diarhea,  gastritis, and  enteritis;  and  influenza,
pneumonia, and bronchitis. Only the diarrhea subcategory is maintained as a specific
cause.  The  second  subcategory is  further  refined  into  infectious and  chronic
components. Other subcategories  for specific  causes of death (Table  1) were chosen to
break up  the three largest of the major categories-infectious and parasitic diseases,
circulatory system diseases, and other causes. Subcategories  were chosen mainly for
substantive  interest. The diarrhea subcategory  is duplicated  among these specific  causes,
but  the  influenza, pneumonia,  and  bronchitis subcategory is replaced by  otheis
somewhat more specific.  These breakdowns also allow distinction of the specific  causes
just noted that fit awkwardly into the major categories.
Among  the  specific causes,  not  all  could be  defined  witS  precision. For
micronutrient disorders, for instance, the codes selected from the revision currently in
use (the ninth) of the International Statistical  Classification  of Diseases, Injuries, and
Causes of Death (ICII-9;  VHO  1977)  were thfose  for disorders of hie thyroid gland,
aneemias,  and avitamntosis.  This group of causes  may be both too broad and too narrow
in different ways, but further specification  was not possible.
Data  on causes of death
Statistics on  causes of death,  by  sex and  age, based  on  the  International
Class-5cation  of Diseases are provided annually to WHO by some 70 countries or
territories. In principle, the  cause of death returns  should be comparable between
countries since  they are based on a common set of procedures for coding and certifying
the cause of death. In practice, however, the comparability  of data across countries is
affected by variations in diagnostic preferences, cultural factors, medical training, the
availability  of diagnostic  aids, and other factors.
In addition, the reliability of national cause of death statistics is a matter of
concern. Broadly speaking, reliability depends on coverage and quality. Deaths not
covered  by the vital registration system are most likely  those in more remote areas with
a cause of death structure typical of high mortality populations. Thus countries with
incomplete coverage are likely to report a cause of death structure biased towards the
chronic diseases pattem  more commonly found  in  urban  areas; the  greater  the
incompleteness, the more biased the data are likely to be. However, of even greater
significance  with respect to reliability  is the extent of medical certification  of the cause
of death, which ensures data qualty. In remote areas with few if any physicians, cause
of death is frequently certified  by lay personnel who have little or no medical training.
Diagnosis is uncertain and many deaths may be coded to symptoms and ill-defined
conditions.4  Esffmatme  and Poetios  of Morality by Cause
Further details about the reliability  of the data and the incorporation of estimates
from subnationai information can be found in Annex A.
The reports on cause of death will be used as they are in tis  paper, without
attempdng corrections  such as regrouping codes or reallocating  the undefined causes.
We rely on the original  WHO procedures for scrutinizing  the data before including them
in their mortality database, and do not attempt any reclassification.  Nor do we attempt
the adjustments that might be needed to take associated  or contributory conditions into
account. It is difficult to nredict how the importance of associated causes will alter as
countries progress throur,t the epidemiological  transition. Certainly  under the regime
of infectious  diseases, malnutrition will frequently  underlie many deaths from diarrheel
diseases or acute respiratory infections. On the other hand, as death Is increasingly
postponed to older ages, multiple pathologies at or near the time of death become
relatively common. As a result,  this  paper  can only  concem itself with  reported
distributions of underlying causes of death.
Estimating  and projecting mortality
Before estimating deaths by cause, overall mortality must be estimated and
projected. This was done country by country, for 187  countries, territories, or groups
of small countries or territories  covering  the entire world (but only aggregate results are
reported). Life  expectancy  and infant mortality  estimates  for the 1985-90  quliquennium
were obtained from the best available  sources; adjustments were made as needed for
agreement with  other  demographic parameters; and  both  forward and  backward
population projections were made.
Each country's experience with mortality  change is used to project its mortality
over the next three quinquennia (1990-2005),  after which each country reverts to the
average mortality trend for the world as a whole. This average trend involves slower
improvements as life expectancy  rises. The procedure involves separate projections of
life expectancy (for each sex) and infant mortality (for both  sexes combined), the
imposition of nonlinear trends on both, and the choice of "split'  life tables. Further
description of the procedures is provided in Annex A.
The projections  using these mortality  trends are the 'standard'  Bank  projections
(see Bulatao  and others 1990).  Two types of alternative  projections were also run: 'fixed
mortality' projections, in which age-specific  mortality rates (for five-year  age groups)
are  taken as fixed at  1985-90 levels throughout  the  projection period;  and  'fixed
distriution'  projections in which mortality  changes as in the standard projections, but
the distribution of deaths by cause within each of the six larger age groups does not
change from 1985.  These alternative  projections allow  some decomposition  of projected
changes in the cause of death structure.
Predicting  mortality rates by cause
The equations for major causes of death predict mortality  rates by cause from age
and sex specific  mortality rates for all causes. These equations are all lnear.  Because
some of the age groups covered a broad range of ages, slight variations  in the equationsMdhod  S
were produced to take into account  differences  among 24 world regions in age structure
within these age groups. This was not necessary for age groups 0 and 14,  for which
therefore only world equations are available. The derivatlon of these  equations is
explained in Hakulinen and others (1986a),  and they are further described in Annex A.
These equations were used to predict mortality  rates by cause wherever repoited
data were not available. The reported data themselves were adjusted proportionally
where necessary to provide the overall mortality levels estimated by the Bank.
New regression equations were estimated for mortality rates from 21 specific
causes, using the rate for the major cause under wllch each falls  as the predictor. These
21 causes  include the  19 listed in  the  second part  of  Table 1 and  two  'other'
subcategories,  under infectious  and parasitic  diseases and under other causes, estimates
for which were obtained as residuals from the major causes. No 'other'  subcategory  is
needed  under  circulatory system diseases because the  subcateores  are  already
comprehensive. The regression procedure is explained in Annex A.
As was done for the major causes, the equations were first used to estimate
mortality rates by cause, age, sex, and country, and for each age-sex group in each
country, rates were adjusted proportionally  if necessary to provide the expected totals.
Deaths from  ill-defined causes were not  reclassified under  other  categories, but
estimates were made of the maximum possible increase in each category from such
reclassification.  Annex A provides details.
Some of the equations were clearly  less robust than those for the major causes.
They appear especially  unreliable for various tropical  diseases prevalent In regions that
are poorly represented in  the WHO database. Experts on partcur  diseases were
shown  the  regression estimates and  asked  about  appropriate  adjustments.  The
responses varied from acceptance of the estimates to detailed recommendations for
revision, based on survey evidence of cases and case-fatality  rates and on individual
judgments. Since the recommendations sometimes appeared considerably at variance
with  reported  deaths and  regression estimates, they are presented  and  discussed
separately.
Results
The demographic  background and projecied trends in overall morlity  will be
described, and then estimates of current mortality by canse will be presented. Next,
trends in the major causes of death will be considered, and patterns of causes of death
by age and sex will be discussed.
lhe demographkc  background
Population estimates and vital rates for each of the six regions, drawn from the
Bank projections, are provided in Annex B. As will be shown, demographic variables
contribute to  important dhanges in cause of death dist  butions. For instance, the
population in deveilping countries over 45 is projected to more than double between
1985  and 2015, rising from 17 to 24 percent of the population. Causes of death, which6  Edstlatt  and  Projecdions  of Mortality  by Cause
are dosely related to age at death, must change accordingly.  Mortality from all causes
will change, with infant mortality in developing countries projected to fall from 78 per
thoand  in 1985  to 43 per thousand in 2015  and life expectancy  at birth in developing
countries projected to rise by five years. This too implies changes in causes of death,
which vary,  by mortality level.
Projected trends in life expectancy  and infant mortality, both showing continual
improvement, are represented in Figures 1 and 2. Based on worldwide and individual
country experience  of mortality  change, these projections  effectively  assume that factors
that have produced improvement in the past, whether socioeconomic  or medical, will
continue to produce improvement in the future. No country was allowed to retrogress
in these projections, although retrogression is of course possible. Even with projected
improvements, however,  regional differentiation will remain  sharp:  by  2015, life
.:xpectancy  in Sub-Saharan Africa  will have barely caught up with 1985  life expectancy
in  the Middle East and  North Africa, and will not have caught up  with 1985 life
expectancy  in any other region.
Current regional crude death rates vary as one would expect, beirg  dearly
highest in Sub-Saharan Africa and lowest in Latin America and the Caribbean. The
latter region has  more young  people than  the  developed country  regions, which
accounts  for its lower risk of death. With the projected improvements  in life expectancy,
the crude death rate is not expected to fall monotonically.  Once the rate reaches a point
around 5 to 10 per thousand. regions generally experience  a bottoming out of decline
and then a slight increase in deaths as their elderly populations increase. Given these
trends,  variability across regions in  crude  death  rates  is  projected  to  diminish
considerably  by 2000  and 2015.
Current  causes of death
Estimated mortality  rates by major cause are shown in Table  2 by sex and region,
but wnthout  age breakdowns. (Three  Asian subregions-India, China including Taiwan,
Hong Kong, and Macao,  and other Asia are also shown.) Patterns for 1970  and 1985  will
be considered first. The leading causes of death for the world as whole for both 1970
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Table  2. EstImated and  projected  mortality rates  (per 100,000), by  major cause, sex, and
region,  1970-2015
1970  19850  0  2015
Region  and  cau  Male  Female  Male  Female  Mak  Femak  Male  Female
World
AU  causes  1293  1281  1064  1004  863  802  880  776
Infections  449  449  318  294  176  179  140  133
Neoplasms  95  96  108  96  108  98  128  114
Circulatory  297  324  262  286  292  283  339  314
Pregnancy  0  13  0  9  0  9  0  7
Perinatal  86  70  79  59  48  36  37  27
lijury  93  40  97  56  78  31  79  32
Other  273  289  201  204  161  167  157  150
Developed  Countries
AU  causes  1054  1069  1W  1013  997  963  1161  1059
Infections  146  112  109  74  78  59  90  63
Neoplasms  167  163  203  172  182  170  213  188
Circulatory  463  552  473  563  486  536  575  597
Prepancy  0  2  0  1  0  1  0  1
Perinatal  26  10  15  10  13  9  13  7
Injury  99  51  87  40  77  37  80  39
Other  153  180  161  154  160  152  191  163
Develping  Conties
All  causes  1383  1373  1070  1001  830  759  823  714
Infections  564  595  382  368  200  211  150  148
Neoplasms  68  68  78  70  90  79  111  98
CIrculatory  234  225  198  192  244  216  291  252
Pregnancy  0  18  0  12  0  11  0  9
Perinatal  109  96  98  75  56  43  42  31
Injury  91  35  100  62  78  29  79  30
Other  318  336  213  221  162  171  150  147
Indusal  Aiaet
All causes  1036  1021  986  950  1007  943  1173  1045
Infections  106  85  82  66  64  47  68  38
Neoplasms  186  169  240  192  196  171  236  200
Circulatory  500  567  461  518  513  551  615  639
Pregnancy  0  0  0  0  0  0  0  0
Perlnatl  21  7  8  5  10  6  10  5
Injury  98  58  74  40  70  36  74  40
Other  125  135  120  128  154  131  171  123
Nonmarkd
All causes  1089  1155  1162  1126  980  1000  1139  1082
Infections  224  159  158  88  103  79  128  106
Neoplasms  129  152  136  135  158  169  173  168
Crculatory  392  524  495  644  437  509  505  526
Pregnancy  0  4  0  3  0  2  0  2
Perinata  37  15  28  17  20  13  19  11
Injury  100  40  109  39  90  38  90  37
Other  209  260  237  200  172  189  225  231
Latin  Amerioa  and  C  Jbem
All causes  1097  903  883  706  677  557  722  594
Infections  366  301  211  177  100  86  67  55
Neoplasnms  79  76  76  70  94  86  122  109
Circulatory  238  214  228  1%  242  215  306  275
Pregancy  0  12  0  6  0  4  0  3
Perinatal  61  42  65  44  40  28  30  20
Injury  98  31  90  29  76  28  78  29
Other  255  227  213  184  124  111  119  1028  Edbnate and Projectiom  of Mortality  by Cause
Table 2 (continued)
1970  1985  2000  201
Region  and  ease  Male  emal  Male  Fmale  Male  Femae  Male  Femaje
Sub-Snm  Afice
ADl  caues  2163  1882  1727  1448  1196  1024  947  785
Infections  1070  937  817  683  498  430  346  286
Neoplasns  52  57  52  55  54  55  60  60
Circulatory  243  226  2D9  191  182  169  180  162
Pregnay  0  27  0  21  0  17  0  14
Perinata  200  157  167  129  119  90  82  61
Injury  108  39  96  34  86  30  82  28
Other  491  438  386  334  258  233  1%  174
Mlk  East  and  North  Aftia
All causes  1563  152)  1184  1121  775  733  691  624
Infections  624  653  459  473  2D9  237  142  164
Neoplasms  60  56  65  60  69  62  81  70
Crcuatory  250  224  200  183  191  171  209  176
Pregnancy  0  21  0  13  0  12  0  10
Perlnata  140  126  120  97  73  57  52  39
Injury  90  37  80  32  75  28  76  28
Other  400  404  260  263  157  166  131  137
Ada
AMl  causes  1280  1342  963  946  784  736  833  734
hnfecdons  506  577  319  323  149  176  110  119
Neoplasms  70  70  85  74  101  87  130  113
Crculatory  230  227  191  194  268  235  338  292
Pregnany  0  17  0  11  0  10  0  8
Pednatal  98  91  88  67  42  32  30  22
Injury  87  34  105  78  77  29  79  31
Other  289  327  175  199  147  167  145  149
bdia
All  causes  1491  1575  1158  1165  879  790  846  745
Irdections  600  707  478  476  215  239  152  175
Neoplasms  70  66  43  51  88  74  108  91
Cin~uLatory  270  249  145  126  253  2D4  295  239
Pregnanc  0  27  0  22  0  12  0  10
Perinatal  123  122  168  132  60  48  40  30
Injury  96  35  85  65  82  28  84  29
Other  332  369  239  293  180  185  167  171
All  causes  978  1115  777  793  700  693  W  738
Infections  354  449  186  2D4  63  104  48  46
Neoplasms  76  78  126  98  123  103  167  144
CIrculatory  205  224  216  249  306  276  417  368
Pregnacy  0  8  0  2  0  7  0  4
Pelnata  63  60  34  22  23  17  18  13
Injury  78  34  127  111  71  30  72  34
Other  203  263  87  106  114  156  125  129
her  Asia
Al causes  1603  1482  1W  938  802  739  793  715
Ifections  686  657  354  338  206  213  150  158
Neoplasms  59  59  67  63  79  76  102  95
Ciulatory  228  2D6  2D4  182  226  209  274  246
Pregnancy  0  21  0  14  0  13  0  10
Perinatal  133  110  81  62  49  36  35  25
Injury  94  35  90  36  81  28  84  29
Oher  403  394  251  244  160  163  149  152Ruudis  9
and 1985  were infectious  and parasitic  diseases and circulatory  system diseases, the first
more important in developing countries and the second more important in developed
countries. Like  infectious  and parasitic  diseases, certain perinatal conditions were much
more important for developing countries, but over all countries accounted for only a
fourth or a fifth as many deaths in 1985. Like circulatory system diseases, neoplasms
were more important in developed than in developing countries, but over all countries
accounted for only a third as many deaths. The other causes category and injury and
poisoning provide weak contrasts between developed and developing countries, and
complications  of pregnancy accounts for a small proportion of deaths.
Figure  3 compares these results with estimates  that Hakulinen and others (1986a)
made  for  1980. Although  the  equations  were  the  same,  Hakulinen and  others
incorporated  earlier reported  data  for  fewer  countries.  Nevertheless, results  are
generally consistent, with their estimated rates for 1980 usually being intermediate
between our 1970  and 1985  estimates. Comparisons  for specific  regions are complicated
by some differences  in country groupings, but also show general agreement. For Sub-
Saharan Africa,  Hakulinen and others did assume slightly  higher overall  mortality  levels
than we use, but their distribution of deaths across causes is still similar to ours.
Taken at face  value, these estimates  also indicate that substan'  A change can take
place in a short period. For developing countries, the mortality rme for infectious and
parasitic diseases is estimated to have declined 17 percent from 1970 to 1980, and 22
percent from 1980  to 1985.
Breakdowns for  1985 of  the  three  largest categories of  major causes  are
summarized in Table 3, which gives numbers of deaths for both major and specific
causes. Table 4  provides mortality rates standardized  using  the  1985 world age
structure. (Annex B gives rates and deaths by sex, age, and region.)
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Devel-  Devel- Indus-  Non-  haran  North
Cause  World  oped  oping  trial  market  LAC  Africa  Africa  Asia
All causes  49899  12047  37852  7313  4735  3183  7203  4314  23151
Infectious,  parasitic  14764  1061  13704  558  503  778  3403  1743  7780
Diarrhea  2997  20  2977  5  15  201  1158  507  1q11
Tuberculosis  844  39  805  13  25  48  119  76  562
Acute respiratory  5549  422  5127  271  151  286  1407  741  2693
Measles  421  1  420  0  1  16  196  87  121
COPD  1943  334  1608  248  87  113  226  160  1110
Polio  25  1  25  0  0  2  3  2  18
Yellow  fever  8  0  8  0  0  0  2  1  5
Malaria  146  0  146  0  0  6  20  16  105
Schistosoniiasis  12  0  12  0  0  0  0  1  10
Intestinal parasites  133  3  130  0  2  7  41  18  65
Other Infectious  2686  240  2446  20  221  99  230  135  1981
Neoplasrns  4903  2190  2714  1629  560  294  242  235  1943
Circulatory  13208  6075  7133  3704  2371  848  909  715  4661
Ischemnic  heart  3948  2426  1522  1407  1019  213  216  19G  904
Cerebrovascular  3813  1547  2266  873  674  176  193  158  1738
Other cardiovascular  3705  1603  2103  1075  527  302  347  254  1199
Diabetes  507  159  348  129  30  62  55  42  189
Certain degenerative  1235  340  895  220  120  96  97  70  631
Pregnancy  225  8  218  0  7  12  48  23  134
Perinatal  3321  143  3178  51  92  218  672  408  1880
Injury, poisoning  3694  729  2965  429  299  239  294  212  2220
Other  9784  1842  7941  941  902  795  1635  978  4534
Mental disorders  95  46  50  36  10  5  4  3  38
Oral health diseases  3  1  2  0  0  1  0  0  1
Micronutrient  252  42  210  20  23  23  45  27  115
Malnutrition  372  26  346  6  20  24  67  37  218
Unspecified  9061  1728  7333  879  849  742  1519  911  4162
As noted  earlier, chronic obstructive pulmonary disease,  though  it is  not
infectious, was included  for convenience among the infectious and parasitic diseases.
This is one of the four specific  causes that dominate this major category.  The other three
are  diarrhea, acute respiratory infections (pneumonia, influenza, acute bronchitis,
whooping cough, and diphtheria, but not measles, which has been separated), and
other infectious and parasitic diseases. In every region, these four account for at least
nine out of ten deaths  from this major cause. Tuberculosis and measles account for a
few percent more,  and  the  remaining categories are  quite  rare. Among the  four
dominant causes, the balance  varies considerably  across  regions. A major contrast is the
greater importance of chronic obstructive pulmonary disease in developed regions and
the greater importance of diarrhea in developing  regions. Acute respiratory infections,
being important in both developed and developing regions, overall is responsible for
a larger share of deaths than either of these two causes. The predominance of these four
specific  causes in these estimates accurately reflects the data reported to WHO. For
instance, for reporting Latin American countries, acute respiratory infections account
for a quarter to a half of all deaths due to infectious diseases in each age-sex  group, andReslts  11





Devel-  Devel-  Indus-  Non-  haran  Noith
Cause  World  oped  oping  trial  market  LAC  Afr*a  Afr*a  Asia
AlU  causes  1046  692  1147  578  894  901  1621  1243  1077
Infectious,  parasitic  308  77  386  43  126  199  658  422  350
Diarrhea  62  2  78  1  5  48  221  114  47
Tuberculosls  18  3  25  1  5  14  33  24  25
Acute respiratory  116  29  141  20  40  72  258  173  120
Measles  9  0  10  0  0  4  31  17  5
COPD  41  18  54  18  16  33  54  49  56
Polio  1  0  1  0  0  0  0  0  1
Yellow  fever  0  0  0  0  0  0  0  0  0
Malaria  3  0  4  0  0  1  3  4  5
Schistosomiasis  0  0  0  0  0  0  0  0  0
Intestinal parasltes  3  0  3  0  1  2  7  4  3
Other infectious  56  24  69  3  59  26  50  35  88
Neoplasms  103  117  92  125  97  91  86  92  93
Clculatory  280  298  255  260  381  272  328  297  237
Ischemicheart  84  119  55  99  164  69  85  82  46
Cerebrovascular  81  74  84  59  106  57  74  68  91
Other cardiovascular  78  78  73  75  86  97  119  103  59
Diabetes  11  8  12  9  5  20  20  18  10
Certain degenerative  26  19  30  17  21  29  30  26  30
Pregnancy  5  1  6  0  2  3  11  7  5
Perinatal  69  20  77  12  32  48  89  76  79
Injury, poisoning  77  56  83  51  67  64  71  61  94
Other  205  123  248  87  189  223  377  288  219
Mental disorders  2  2  2  2  2  2  2  1  2
Oralhealth diseases  0  0  0  0  0  0  0  0  0
Mlcronutrient  5  3  6  2  4  7  12  9  5
Malnutrition  8  3  9  0  6  6  11  8  9
Unspecified  190  115  231  83  177  209  352  269  202
Note: Rates are standardized  using the 1985  world age structure.
acute respiratory infections and diarrhea combined account for three-fourths of deaths
under five.
Among circulatory system diseases, ischemic heart  disease, cerebrovascular
disease, and other cardiovascular  diseases are nearly equal in importance for the world
as a whole. Regionally, ischemic heart disease is responsible for the largest share of
circulatory system disease deaths in developed regions;  cerebrovascular  disease  has the
largest share in Asia; and other cardiovascular  diseases have the largest share in the
remaining developing  regions. All  these categories  are important everywhere, however:
each always accounts for a fifth or more of the  deaths under  the major category.
Diabetes is of lesser importance in these estimates, with less than 5 percent of deaths
under the major category, and nephritis, cirrhosis  of the liver, and ulcers of the stomach
and duodenum account for roughly twice this proportion.12  Estimates  and Projections  of Mortality  by Cause
For the  other  causes  category,  an  attempt  was  made  to  distinguish  mental
disorders,  oral health  diseases, micronutrient  deficiencies, and malnutrition.  Combined
these  accounted  for  under  10  percent  of. other  causes,  however,  leaving  a  large
remainder  unspecified.
Experts were  asked  to comment  on the regression  estimates.  For some causes,
they  provided  their  own  assessments  or  suggested  useful  data.  Mainly  they
recommended  increases  in deaths  from particular  causes  of 130 to  270 percent.  The
largest  of these  increases  was  for malaria,  and  progressively  smaller  increases  were
recommended  for yellow fever, polio, schistosomiasis, and complications of pregnancy
(rable  5). For diabetes,  a reduction  of 6 percent  was recommended.  For diarrhea,  a
proportionally  trivial reduction  was recommended,  but with a substantial shift in deaths
toward  younger  ages.  On the  order of 700 thousand  deaths  could be moved,  per the
expert assessments,  from over age five to under  age five. Although  the recommended
change  in  the  total  number  of deaths  from  all  these  causes  combined  is  modest,
substantial  shifts do occur for particular  age groups.
Could  the  regression  estimates  be  too  low  because  all causes  of death  are
underreported?  This cannot be the explanation for the discrepancies in Table 5 because
the regression  estimates  have  been  adjusted  to  provide  the  correct  overall mortality
levels.
If deaths  from ill-defined causes  were reclassified under  other headings,  could
the regression  estimates be raised to the level of the expert assessments?  The answer
depends  on how the ifl-defined deaths are redistributed.  If they are simply redistributed
proportionally  across all other  categories, each category would  increase  only about 10
percent,  well below the increase required to match the expert assessments.  On the other
hand,  the  ill-defined  deaths  might  be  assigned  to  only  a  few  categories,  on  the
assumption  that the accuracy of reporting  varies. We estimated  the maximum number
of deaths in each category if as many of the ill-defined deaths as possible were included
in it. (These maximum estimates are not consistent,  since they add up  to substantially
Table 5. Comparison of regression estimates of mortality rates and deaths fro=
particular causes and expert assessments, all developing countries, 1985
Rates  per  100.000  Deaths  (000)  Ratio:  Recommend-
Regres-  Regres-  Maxi-  Regressionl ed change  in
Cause  sion  Expert  sion  mum  Expert  Expert  deaths  (000)
Diarrhea  81.2  78.4  2977  na  2876  1.0  -101
Polio  0.7  2.1  25  143  77  3.1  52
Yellow  fever  0.2  0.7  8  54  26  3.3  18
Malaria  4.0  14.6  146  557  537  3.7  390
Schistosomiasis  0.3  0.9  12  92  34  2.9  22
Pregnancy  5.9  13.4  218  403  492  2.3  274
Diabetes  9.5  8.7  348  na  319  0.9  -29
na - not applicable.
Note: Maximum  deaths are obtained  by adding to the initial esdmates all possible deaths from
il-defined causes.Resul  13
more than the total deaths.) The column of maximum estimates in Table  5 shows the
results. In principle, the expert assessments could be attained if substantial numbers of
deaths from il-defined causes were reclassified  under  these specific  categories. This
does not hold in  one case: for pregnancy complications, the number of ill-defined
deaths among women 15-44  is too small to allow the regression  estimates to be adjusted
upward sufficiently.  In this case, the expert assessments could be correct only if deaths
from complications  of pregnancy are misclassified  under other defined causes.
This does not establish that the expert assessments are correct-it  merely shows
one way most of them could be made consistent with the WHO database. Essentialy
the assessments were based on estimates of numbers of cases, whether from survey
data or from informed judgments. Different  sources of error are attached to reports of
cause of death and to estimates from surveys focusing mainly on morbidity. Surveys
may allow greater  care in  identifying cases, but  typicaUy often require additional
assumptions, generaUy from inadequate data,  about  case-fatality rates. Therefore,
choosing between the regression estimates and the expert assessments is difficult, and
details of each are provided separately-the  latter in Annex C, which discusses them
further.
Trends in major causes of death
Given uncertainties in figures for specific  causes, only the major causes are
projected into the future. Figures  4 and 5 shows how the actual numbers of deaths are
expected to change for developed and developing countries. The two most important
major causes show opposite trends,  infectious diseases declining from causing 35
percent of deaths in 1970  to causing 16 percent of deaths in 2015,  while diseases of the
circulatory  system rise, from causing 24 percent of deaths in 1970  to causing 39 percent
of deaths in 2015. The infectious disease trend is mainly due to lower mortality from
this cause in  developing countries, whereas the circulatory disease trend is due to
higher mortality from this  cause in  both  developed and  developing countries.  A
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Figure  5. Deaths  by cause,  developing  countries,  1970-2015
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convenient  inidex for sumnun  ig  these changes is the ratio of deaths  from circulatory
system  diseases  to  deaths  ftom infectious  and  parasitic diseases.  For the  world  as a
w.hole, this ratio is estimated  at 0.7 for 1970, 0.9 for 1985, 1.6 for 2000, and 2.4 for 2015.
Of the remaiIiing five major causes of death,  two follow the trends for these first
two  causes,  certain perinatal  conditions  showing  a decline parallel decline to that  for
inlfectious and parasitic diseases and neoplasms showing  an increase parallel to that for
rcliatrysystem  diseases.  The other causes category  is responsible  for more deaths
than  either  of these  causes  and  is expected to decline, but  somewhat  gradually,  and
possibly because  of better  reporting  rather  than actual change.  Injury  arnd poisoning,
accounting  for 5 to 10 percent  of deaths,  and  complicadtons of pregnancy,  accounting
for under  1 percent  of deaths,  show  no clear trend.
All regions  exhibit the same basic trends,  the differences among them having to
do  rnairly  with  being  more  or  less  advanced  in  the  process  of  epidemiological
transition.  Patternis and  trends  for Asia,  the  region  with  the  largest  population,  are
closest  to  those  for  the  world  as  a whole,  with  Latin America  and  the  Ca^ribean,
indstralnonmarket  econornies,  and  industria  market  econonmies  successivelv more
advanced,  on the one hand,  and  the  Middle East and  North  Africa and  Sub-Saharan
Africa successively less advanced,  on the other. Table 6 gives the ratios of circulatory
system deaths  to infectious  and parasitic disease deaths,  which  effectively summarize
the regional  contrasts.
The greatest  numbers  of deaths  will continue  to be in Asia, where  ahnost  half
of all deaths in the world take place. This proportion  is not projected  to change. For all
causes  cornbined,  in  fact, each region  will contribute  about  the  same proportion  of
deaths in 2015 as in 1985. For particular  causes, some changes are projected,  however,
with  Asia  contibuting  smaller  proportions  of  deaths  from  unfectious and  parasitic
diseases  and  perinatal  conditions  and  larger  proportions  of deaths  from  circulatory
system diseases and neoplasms.  Sub-Saharan African deaths will increase in proportion
for the first two of these causes,  and  industria  market  economy  deaths  will decreaseResults  15
Table 6. Ratio of deaths from circulatory system diseases to
deaths from Infectious and parasitic diseases, by region, 1970-
2015
Region  1970  1985  2000  2015
World  0.69  0.89  1.62  2.39
Developed  countries  3.98  5.73  7.52  7.69
Developing  countries  0.40  0.52  1.12  1.82
Industrial market  5.63  6.64  9.61  11.88
Induswtrial  nonmarket  2.44  4.72  5.24  4.41
Latin America  and Caribbean  0.68  1.09  2.46  4.74
Sub-Saharan  Africa  0.23  0.27  0.38  0.54
Middle East and North Africa  0.37  0.41  0.81  1.26
Asia  0.42  0.60  1.55  2.75
India  0.40  0.29  1.01  1.64
China  0.53  1.19  3.52  8.37
Other Asia  0.32  0.56  1.04  1.69
in proportion  for the last two of these causes.
The projections of mortality by cause are not straightforward  extrapolations from
past  experience,  but  involve a combination  of population  projections  with  predictive
equations  for mortality rates by cause. An alternative,  much simpler, procedure  would
have been  to take the change in percentage  of deaths  due  to a given cause from 1970
to 1985 and  extrapolate  this linearly into the future.  This alternative  procedure  would
have given quite  different  results: for the world  as a whole by 2000, a larger share  of
deaths  due  to  infectious  and  parasitic  diseases  (24  instead  of  21  percent),  a
correspondingly  lower  share  due  to  circulatory  system  diseases  (29 instead  of 35
percent), and smaller variations for the other causes. For specific regions,  the differences
would  have been greater:  for the Middle East and  North  Africa by 2015, for instance,
a linear  extrapolation  would give 39 percent  of deaths  due to infectious  and  parasitic
diseases,  whereas  the regression-based  procedures  give only 23 percent.
Some insight into why the calculations come out as they do can be obtained by
decomposing  future changes in the distribution  of deaths. Such changes maybe  related
to changes in the age-sex structure  of the population,  changes in mortality levels from
all causes  within  age-sex groups,  or changes  in  the  distribution  of deaths  by  cause
within  age-sex groups.  Projections with fixed mortality or fixed distributions  of deaths
by cause can help distinguish  these components  of change, if one accepts the necessary
assumptions:  for instance,  that mortality can change without a simultaneous  change in
the  distribution  of deaths  by  cause,  or,  in  other  words,  that  a  similar  proportional
change  in deaths  across causes is conceivable. Table 7 shows,  first, the percentage  of
deaths  due  to each  cause in 1985; second,  the  projected  increase  or decrease  in this
percentage  (by 2000 and  2015) due  to contemplated  changes  in the age-sex structure,
assuming  fixed mortality;  third,  the  further  projected  increase  or  decrease  in  this
percentage  if mortality  is allowed to decline but  the distibution  of deaths by cause is
fixed within age-sex groups;  and fourth,  the further projected increase or decrease  due
to changes  in the distribution  of deaths by cause within age-sex groups.  Totaling the
components  for 2000 for any given cause and adding the 1985  figure gives the projected
percentage  of deaths  due  to that cause by 2000.16  Estimates  and Projections  of Mortality  by Cause
Table 7. Percentage  distrihution of deaths by major cause in 1985  and incremental changes
expected by 2000  and 2015  from three factors, world and developed and developing
countries
Percentage  point  change  Percentage  point  change
1985  by 2000  due to  kg  2015  due to
percentage  Age-sex  Mortality  Distrtiu-  Age-sex  Mortality  Distdbu-
Region  and  cause disttibution  structure  change  tion  change  stmeture  change  tion change
World
Infections  29.6  -1.1  -2.0  -5.2  -1.4  -3.3  -8.4
Neoplasms  9.8  0.6  0.8  1.1  1.1  1.1  2.6
Circulatory  26.5  2.2  2.9  2.9  3.3  4.4  5.3
Pregnancy  0.5  0.1  -0.1  0.0  0.1  -0.2  0.0
Perlnatal  6.7  0.8  -1.2  0.3  -1.8  -1.6  0.6
Injury  7.4  -0.8  -0.4  0.4  -1.1  -0.7  1.1
Other  19.6  -0.3  0.0  0.4  -0.1  0.2  -1.2
Developed  Countries
Infections  8.8  -1.1  -0.2  -0.6  -1.1  -0.2  -0.6
Neoplasms  18.2  0.6  0.0  -0.9  0.8  -0.2  -0.7
Clrculatory  50.4  2.5  1.1  -1.8  2.8  1.5  -1.8
Pregnancy  0.1  0.0  0.0  0.0  0.0  0.0  0.0
Perlnatal  1.2  -0.3  -0.2  0.4  -0.4  -0.2  0.3
Injury  6.1  -05  -0.6  0.9  -0.9  -0.8  1.0
Other  15.3  -1.2  -0.1  2.0  -1.2  -0.1  1.9
Devlopig Countnes
Infections  36.2  -1.9  -1.8  -6.6  -3.0  -3.0  -10.8
Neoplasms  7.2  1.0  0.7  1.7  1.8  1.0  3.6
Crculatory  18.8  3.2  2.6  4.3  5.2  3.9  7.4
Pregnancy  0.6  0.1  -0.1  0.0  0.1  -0.2  0.0
Perlnatal  8.4  -1.1  -1.3  0.3  -2.6  -1.8  0.7
Injury  7.8  -0.9  -0.3  0.2  -1.2  -0.6  1.1
Other  21.0  -0.3  0.2  -0.1  -0.2  0.6  -2.1
Table 7 indicates that the three  components can operate in  the  same or in
opposite  directions. For instance, population aging, lower mortality (especially at
younger ages), and changes in the distribution of deaths all contribute to the decline in
infectious diseases. On the other hand, population aging and lower mortality reduce
the importance of injury and poisoning, but distribution change raises their importance
in relation to other causes of death.
WWch  of the three components  exerts the greatest effect  varies considerably  from
cause to cause. The largest effect overall is that of distrbutional change on infectious
and parasitic diseases, but in this case the other two components mostly operate in the
same direction, namely to reduce the proportion of deaths from this cause. The three
components are also consistent in their effect  on raising the importance of circulatory
system diseases in developing countries, but in developed countries the components
work in opposite directions. Therefore,  both demographic and epidemiological  change
will have roles in modifying mortality by cause in the future.Results  17
Age-sex specific patterns
Patterns by age and sex are roughly similar across regions, but also different in
many details. (Annex B gives all the estimates.) Between men and women, differences
are small, except with regard to complications  of pregnancy. Across ages, mortality is
lowest at 5-14 and 15-44, about five times as high at 1-4 and 45-64, and about fifty
times as high at 0 and 64 and above. Concerning the percentage of deaths from each
cause at each age, the patterns are roughly as follows. Infectious and parasitic diseases
decline in importance with age (though they are more prominent at age 1-4 than at 0,
give the  predominance of certain perinatal causes among infant deaths), whereas
circulatory system diseases and neoplasms increase in importance with age. Other
causes are essentially  stable across ages. Injury and poisoning is most prominent at age
15-4,  perinatal  conditions of  course  significant at  age  0,  and  complications of
pregnancy notable at age 15-44.
Over time, mortality rates by cause show variable changes. For infectious and
parasitic  diseases and for the other causes category,  reductions are fairly constant across
age groups,  except for being somewhat smaller at 65 and  above. In  contrast, for
circulatory system diseases and  for injury and poisoning, reductions over time are
strongly linked to age, being much greater at younger ages. For neoplasms, increases
over time are actually more frequent than reductions, and are expected to occur in all
regions, but most notably in Sub-Saharan  Africa.
To obtain the previously reported estimates for all ages, deaths were simply
added up  across age groups. Should deaths at different ages be given equal weight?
Several arguments to the contrary are possible. For instance, fewer deaths at the oldest
ages are iikely  to be 'premature'  than at younger ages, and from the perspective of
prevention, deaths at the oldest ages might therefore deserve less attention. Also,
deaths at younger rather than older ages might be seen as depriving individuals of a
larger  number  of  potential  years  of  life. To illustrate  the  effects of  alternative
weightings, Table 8 compares the percentage d  - ' ition of deaths by cause with the
percentage distribution of deaths under 65 and . .'.. the percentage distribution across
causes of potential years of life lost by death.  Years lost are calculated under  the
simplifying assumptions that life expectancy is 75 and that deaths in each age group
from each cause occur at the mean for that age group from all causes in the world as
a whole in 1985.
Weighting deaths at younger ages more heavily increases the prominence of
infectious and parasitic diseases, perinatal conditions, and injury and poisoning (the
latter mainly in developed countries) and reduces the prominence of circulatory  system
diseases and neoplasms. The effects  on the remaining causes are weak or inconsistent.
Thus infectious and parasitic diseases account for a little over a third of deaths in
developing countries in 1985  but a half of all potential years of life lost. In comparison
to infectious and parasitic diseases, circulatory system diseases will account for more
deaths by 2000,  but not for as many deaths under 65 until 2015,  and even by 2015  for
less than half as many potential years of life lost. Nevertheless, whether weighted or
unweighted,  the percentages mostly shuw similar trends, especially in decreases for
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Table  8. Percentage distribution  by  major cause of all deaths,  deaths  under  65, and
potential  years of life lost, world  and  developed  and  developi-.  countries,  1970-2015
1970:  Percent  of  1985:  Pcent  of  2000:  Percent  of  2015:  Percent  of
Deaths  Life  Deaths  Life  Deaths  Life  Deaths  Life
Region  and  All  under  years  All  under  yeats  All  under  years  All  under  years
cause  deaths  65  lost  deaths  65  lost  deaths  65  lost  deaths  65  lost
World
Infectious  35  45  50  30  39  44  21  30  37  16  23  32
Neoplasms  7  5  2  10  8  4  12  12  6  15  15  9
CIrculatory  24  12  6  26  13  7  35  20  10  39  25  14
Pregnancy  1  1  1  0  1  1  1  1  1  0  1  1
Perlnatal  6  9  12  7  11  15  5  10  16  4  9  15
Injury  5  7  6  7  10  10  7  10  9  7  12  11
Other  22  21  23  20  19  20  20  17  20  19  16  18
Developed  Countries
Infectlous  12  16  20  9  13  18  7  4  5  7  3  3
Neoplasms  16  18  12  18  21  14  18  27  21  18  29  24
Circulatory  48  28  16  50  29  17  52  39  29  53  41  32
Pregnancy  0  0  0  0  0  0  0  0  0  0  0  0
Perinatal  2  6  11  1  4  8  1  5  14  1  5  14
Injury  7  17  21  6  15  17  6  16  20  5  15  19
Other  16  16  20  15  19  25  16  9  10  16  7  9
Developing  Countrks
Infectious  42  49  53  36  42  46  26  33  39  19  26  34
Neoplasmis  5  4  2  7  6  3  11  10  5  14  14  8
Circulatory  17  10  5  19  11  6  29  17  9  35  23  13
Pregnancy  1  1  1  1  1  1  1  1  1  1  1  1
Perlnatal  7  10  12  8  12  16  6  10  16  5  9  16
Injury  5  5  4  8  10  9  7  10  9  7  11  10
Other  24  22  23  21  19  20  21  18  20  19  17  19
Discussion
Since the expert assessments imply that at least some of the regression  estimates
are too low, we now consider the quality of these estimates and the biases that may
exist in them.
The source of particular estimates should be borne in mind. For several  regions,
the current and past estimates are based substantially  on data reported to WHO. Table
9 shows the  proportions  of regional populations covered by  reported  data.  (The
U.S.S.R. is not counted as covered, but China and rural India are.) The 1970  and 1985
estimates for industrial market economies  are drawn almost entirely from reports. This
is true to a lesser extent for Latin America  and the Caibbean and industrial nonmarket
economies. The situation for Asian data is more ambiguous because of reliance on
special survey data for China and India. For Sub-Saharan  Africa and North Africa  and
the  Middle East, on the  other hand,  practically all the  1970 and  1985 figures are
produced from the regression models.
As noted earlier, estimates based entirely on reports to WHO are not free from
potential bias. The general issues of reliability and comparability  have already been
noted, but in addition some aspects of the coding appear not to conform with expertDiscussion  19
Table  9. Percentage of regional population
covered by  reports to WHO or sample sur-
veys, by  year
Region  1970  1985
World  28  59
Developed  countries  74  76
Developing  countries  10  53
Industrial market  economies  98  100
Industrial nonmarket econo-  29  32
mies
Latin America  and Caribbean  62  53
Sub-Saharan  Africa  0  0
Middle  East an( North Africa  14  2
Asia  2  71
Note: For 1985,  the U.S.S.R. is not counted as
covered.  China and rural India in 1985  are the only
cases covered  by sample surveys rather than regis-
tration.  Urban India is not counted as covered.
expectations.  For example, substantial  deaths  from diarrhea  at older ages were judged
improbable. Nevertheless, on the average  across  reporting countries  in 1985,  40 percent
of all deaths from this cause occurred  at age 65 and older, and the proportion exceeded
80 percent in  countries like Norway and Japan, with presumably reliable reports.
Misclassification  cannot be excluded as an explanation, but cannot be confirmed  with
available data.
Further potential  problems exist  with the regression-based  estimates,  where they
are used for 1970  and 1985  for countries with no reported data, as well as for 2000  and
2015 for all countries. Both statistical and  substantive criteria could be applied in
assessing these results.
Statistically,  the equations for major causes of death produced patterns for 1970
and 1985 consistent with those produced by Hakulinen and others (1986a)  for 1980,
using the same equations but different life tables and regional groupings. Hakulinen
and others argued that their results had many similarities  to previous results by Preston
(1976),  who estimated equations that were not age-specific.  They also argued that the
procedure was insensitive to  choice of life tables, which appears borne out by the
similarities  between their results and these.
To assess the regression procedure, the equations were applied to the reporting
countries for 1985  to see whether predictions would match reports. This comparison is
permissible because the equations for major causes had been separately estimated (by
Hakulinen and others) with other data; the procedure is less informative  regarding the
equations for specific  causes, which were estimated using the reported data in the
comparison. Table 10 shows, however, that the reported distribution by major causes
is more doselv approximated  by predictions than is the distribution by specific  causes.
For the major causes, indices of dissimilarity  between percentage distributions range
from 5 to 13 among the four regions in Table 10. For specific  causes under infectious
diseases, these indices range from 12 to 34; for specific  causes under circulatory  system20  Estimates  and Projections  of Mortality  by Cause
Table  10. rredlcted  and  reported  percentage  distributions  of deaths  by cause for reporting
countries grouped  by  region,  1985
Industrial  (24Y  Nonmarket  (8).  LAC (26)  Asia  (7)
Cause  Predicted  Reported Predicted  Repored Predicted  Reported Predicted  Reported
Percent of all causes
Infections  8  8  20  11  23  20  31  32
Neoplasms  17  22  12  12  11  11  9  9
Circulatory  51  51  38  50  31  32  25  20
Pregnancy  0  0  0  C  0  0  1  1
Perinatal  1  1  2  2  7  7  6  8
Injury  6  6  6  6  7  10  6  11
Other  17  13  22  19  21  b  22  19
Percent of infections
Diarrhea  7  1  16  3  22  28  25  9
Tuberculosis  4  2  8  5  6  6  5  8
Acute respiratory  42  49  43  30  41  31  43  33
Measles  1  0  2  0  2  1  3  1
COPD  33  45  19  17  16  b  12  16
Polio  0  0  0  0  0  b  0  0
Yelow fever  0  0  0  0  0  0  0  0
Malaria  0  0  1  0  1  0  1  2
Schistosomiasis  0  0  0  0  0  0  0  0
Entestinalparasites  0  0  1  0  1  1  1  1
Other Infections  12  4  10  44  12  17  9  31
Percent of circulatory
Ischemnlc  heart  30  38  29  43  29  28  27  17
Cerebrovascular  24  24  24  28  23  19  23  42
Other cardiovascular  34  29  34  22  34  37  34  23
Diabetes  6  3  6  1  6  8  6  3
Certain degenerative  7  6  7  5  9  13  9  15
Percent of other causes
Mentaldisorders  2  4  1  1  1  c  1  1
Oralhealth diseases  0  0  0  0  0  c  0  0
hicronutrient  3  2  3  3  3  c  3  2
Malnutrition  1  1  2  2  2  c  3  5
Unspecified  94  93  94  94  94  c  93  91
unumber  of countries included  in the comparison.
"With  no reported data for this category,  it was assumed to be equal to the predicted value to permit
comparisons  for other categories.
'No data.
diseases, they range from 8 to 24; and for specific  causes under other causes, they range
from 1 to 3. Generally, the distributions for nonmarket economieF  are more poorly
predicted than those for other regions.
fwor  particular  causes, predicted  percentages  are  higher than reported percentages
in  some regions,  lower in  others.  For  circulatory system  diseases,  for instance,
predictions are too high in Asia, too low in nonmarket economies. One might draw
implications from such comparisons about the  possible directions of bias  in  the
estimates  for nonreporting countries, but only if one assumes similar  mortality  patterns
in nonreporting as in reporting countries.Dbsussion  21
For the specific  causes, the statistical  adequacy of the equations varies by cause,
as indicated earlier using coefficients  of determination. Those causes of death that have
distinctive patterns in Africa  and the Middle East, and possibly in Asia, may be poorly
estimated for these regions. This does not mean that diseases especially  prevalent in
these regions are underestimated: their prevalence might still  be properly represented
by extension of pattems  across developed and Latin American countries. Rather it
means that  causes of death that show important discontinuities between reporting
countries and nonreporting countries may be poorly estimated for the nonreporting
countries. Unfortunately, without reports for all regions, one cannot tell defiritively
which causes of death these are.
Even if the equations were entirely  accurate  for the present, projecting them into
the future would still  raise several  issues. Future estimates also depend on assumptions
about age structure, about current vital rates,  and about trends in  these variables.
Furthermore, other unexpected changes could alter the outlook. Estimates for new
causes of death cannot be generated by this procedure. For Human Immunodeficiency
Virus (HIV)  infection,  in particular, this limitation  may have significance  for the broader
picture. Besides  changes in diseases, changes in medical technology, in life styles, in
health and safety measures, and in the delivery of health services, as well as in the
nature and quality of cause of death reports, could change the picture. All that the
projections provide  is  a  hypothetical picture  based  on  somewhat  contradictory
assumptions: that mortality decline will be extended into the future, extending past
trends,  but  that  historical patterns  associating particular  disease categories with
particular mortality levels will remain as they are.
Despite these caveats and uncertainties,  the broad patterns in the estimates and
projections are certainly plausible: the regional contrasts and the way some of them
persist over time; the expected increase in circulatory system diseases as a cause of
death;  and  the  separate  contributions  of  age  structures,  mortality  levels,  and
epidemiological  change to variation in distribution of deaths by cause. The implications
worth drawing from these broad patterns depend on the questions one asks. As Table
8 showed with  alternative percentage distributions, from different perspectives the
figures reveal different patterns. One clear  implication  from any perspective, however,
is that better data on cause of death are essential. In this regard, WHO is working with
countries to strengthen their cause of death information  systems as an essential  support
for health monitoring.
Annex  A. Methodology
This  annex  provides more  detail about  the  data  on  causes of  death,  the
projection of mortality levels, and the regressions to decompose overall mortality into
major and specific  causes. The reclassification  of deaths from unspecified causes is also
discussed.
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Table  Al.  Regional  grouping  of  countries  and  territories
Industrial Market  Brazil  Gabon  Qatar
Economies  Chile  Gambia, The  Saudi Arabia
Australia  Colombia  Ghana  Syrian Arab Rep.
Austria  Costa Rica  Guinea  Tunisia
Belgium  Cuba  Gulnba-Bissau  Turkey
Canada  Dominica  Kenya  United Arab Emirates
Channel Islands  Dominican Rep.  Lesotho  West Bank
Cyprus  Ecuador  Liberia  Yemen, People's Dem.
Denmark  El Salvador  Madagascar  Rep. of
Finland  Grenada  Malawi  Yemen Arab Rep.
France  Guadeloupe  Mall  Other North Africa
Germany, Fed. Rep. of  Guatemala  Mauritania
Greece  Guyana  Mauritius  Asia and the Pacfikc
Iceland  Haiti  Mozambique  Bangladesh
Ireland  Honduras  Namibia  Bhutan
Italy  Jamaica  Niger  Brunei
Japan  Martinique  Nigeria  Cambodia
Luxembourg  Mexico  Reunion  China (excluding
Malta  Montserrat  Rwanda  Taiwan)
Netherlands  Netherlands AntiUes  Sao Tome and Principe  Fiji
New Zealand  Nicaragua  Senegal  French Polynesia
Norway  Panama  SeycheUes  Guam
Portugal  Paraguay  Sierra Leone  Hong Kong
Spain  Peru  Somalla  India
Sweden  Puerto Rico  South Africa  Indonesia
Switzerland  St. Kitts and Nevis  Sudan  Kiribati
United Kingdom  St. Liiu.a  Swaziland  Korea, Dem. People's
United States of  St. Vincent and  Tanzania  Rep. of
America  the Grenadines  Togo  Korea, Rep. of
Other Europe  Suriname  Uganda  Lao People's Dem. Rep.
Other North America  Trinidad and Tobago  Zaire  Macao
Uruguay  Zambia  Malaysia
Industrial Nonmarket  Venezuela  Zimbabwe  Maldives
Economies  Virgin Islands (U.S.)  Other West Africa  Mongolia
Albania  Other Latin America  Myanma
Bulgaria  Middle East and  Nepal
Czechoslovakia  Sub-Saharan  Africa  North Africa  New Caledonia
German Dem. Rep.  Angola  Afghanistan  Pacific  Islands
Hungary  Benin  Algeria  Papua New Guinea
Poland  Botswana  Bahrain  Philippines
Romania  Burkina Faso  Egypt, Arab Rep. of  Singapore
U.S.S.R.  Burundi  Gaza Strip  Solomon Il4ands
Yugoslavia  Cameroon  Iran, LIslamic  Rep. of  SriLanka
Cape Verde  Iraq  Taiwan
Latin America and  Central African  Rep.  Israel  Thailand
the Cribbean  Chad  Jordan  Tonga
Antigua and Barbuda  Comoros  Kuwait  Vanuatu
Argentina  Congo, People's Rep.of  Lebanon  Viet Nam
Bahamas  C8te d'Ivoire  Libya  Western Samoa
Barbados  Djibouti  Morocco  Other Micronesia
Bellze  Equatorial Guinea  Oman  Other Polynesia
Bolivia  Ethiopia  PaldstanAnnex  A. Methodology  23
Data on causes of death
The cause of death data for countries and territories  used in this analysis can be
divided into two groups. Table A2 lists those countries, mostly developed, for which
the cause of death data are reasonably reliable, although comparability may still be
uncertain. Table  A3  lists those countries  for which the data are less reliable  and presents
two indicators of reliability:  coverage, as computed from the annual estimated number
of deaths, and quality, as measured by the proportion of deaths coded as due to ill-
defined conditions. Some countries that  report  data  have been  exduded  because
coverage and qualicy  are sufficiently  poor to render the data unusable.
Of the countries included, China, India, and the U.S.S.R.  have data with special
characteristics.  The Chinese data are from a survey covering  57 million  urban residents
and 42 million rural residents spread over the eastern part of the country. The 580
thousand deaths recorded, though only 7 percent of estimated annual Chinese deaths,
should  be reasonably indicative of the  mortality pattern  for 70-80 percent of the
population.  ICD-9 codes were used,  and  all the major causes and the  majority of
specific causes can be identified. Sample deaths were weighted to reflect the  total
population.
The Indian data are from a 1986  cause of death survey of 1,200 rural primary
health care centers spread throughout India, and covered 10,075  male and 8,187  female
deaths (0.2  percent of estimated Indian deaths). Coding was idiosyncratic,  but the major
causes and  some of the specific  causes were still distinguishable. Without the base
population,  mortality rates could not be calculated from the survey. We arbitrarily
assumed that age-specific  urban mortality  rates were fixed  percentages of rural rates (at
age 1-4, 37.5 percent; at ages 0, 5-14, and 15-44,  67 percent; at age 45-65, 75 percent;
and at age 65 and above, 100  percent). With the rural population at 74.5 percent of the
total and with a particular age structure of mortality for the country as a whole drawn
from Bank projections (see below), we then generalized the survey results to cover the
rural population and estimated urban deaths by cause from the regression equations
dussed  below.
For the U.S.S.R., the data reported to WHO permitted identification of deaths
due to diarrhea, most circulatory  system diseases (exduding cirrhosis of the liver) and
measles. Regression estimates were used to fill in the other causes.
For most other countries, data were available  on each cause of death. The major
exceptions  were the Latin  America  and Caribbean  countnes, for which 1970  but not 1985
data  were available on  other causes and  four specific causes (chronic obstructive
pulmonary disease, polio, mental disorders, and  micronutrient disorders). Again,
regression estimates filled in for the missing data.
Projecting mortality
As noted above, the projection of mortality involved separate projections of life
expectancy and infant mortality and the selection of 'split'  life tables.24  Estimates  and Projections  of Mortality  by Cause
Table A2. Countries or territories with reliable reports on causes
of death, and year of data used, by region
Country  or territory  Year  County or territory  Year
Industria  market  economies  Industrial  nonmarket  economies
Australia  1985  Bulgaria  1985
Austria  1985  Czechoslovakia  1985
Belgium  1986  German Dem. Rep.  1985
Canada  1985  Hungary  1985
Denmark  1985  Poland  1985
Finland  1985  Romanla  1984
France  1985  U.S.S.R.  1986
Germany,  Federal  Rep. of  1985  Yugoslavia  1985
Greece  1985
Iceland  i985  Latin  America  and  the Caribbean
Ireland  1985  Argentina  1985
Italy  1985  Chile  1985
Japan  1985  Costa  Rica  1985
Luxembourg  1985  Cuba  1985
Malta  1985  Uruguay  1985
Netherlands  1985
New Zealand  1985  Middk East  and  North  Africa
Norway  1985  Israel  1985
Portugal  1985
Spain  1985  Asia
Sweden  1985  Hong Kong  1985
Switzerland  1985  Singapore  1985
United Kingdom  1985
United States of America  1985
Note: Data for around 1970  for all these countries or territories  except the
German Democratic  Republic,  the U.S.S.R., and Israel were also used. The
U.S.S.R. data, though considered  reliable,  could not provide estimates  for
many of the specific  causes used here.
Life expectancy  is assumed to rise over time following  a logistic curve that has
a minimum of 20 and a maximum  of 75.8  for males or 82.5 for females. The slope of the
curve is estmated using a regression equation that has on the right-hand side the slope
over the previous quinquennium and the female secondary enrolment ratio (or the
percent urban, in the few cases where this is not available).  In comparisons among a
variety of countries, the median slope in the past, applying the logistic curve, was
-.035, and the quartiles were -.017 and -.053. To eliminate extreme trends-including
a few increases  in mortality-no  country is allowed to have a slope falling outside these
quartiles. The estimated slope, or the quartile value if appropriate, is assumed to apply
for three quinquennia, after which all countries are assumed to revert to the median
slope.
Infant mortality is assumed to fall over time also following  a logistic  curve, from
a maximum of 200 per thousand to a minimum of 4 per thousand. The median slope
across a variety of countries with data was .052,  with the quartiles being .025  and .120.
A  slope  is  estimated  for  each  country  from  its  performance  in  the  preceding
quinquennium, and applied for three quinquennia, unless this slope falls outside the
quartiles, in which case the appropriate quartile value is used.Anne  A. Methodology  25
Table  A3. Countries  or territories  with  less reliable  reports  on causes of




Percent  of  to ill-de-
Year  of  estimated  total  fined
Country  or territory  data  used  Number  deaths  conditions
Latin  Amenca  and  the Caribbean
Antigua and Barbuda  1983  300  na  na
Bahamas  1985  1200  na  <5
Barbados  1984  2000  95  <5
Belize  1984  700  na  15
Dominica  1984  400  na  na
Dominican  Rep.  1985  28000  62  15
Ecuador  1985  51000  70  15
El Salvador  1984  29000  62  20-25
Guatemala  1984  66500  86  10
Guyana  1984  4800  91  10
Martdnique  1985  2200  88  10
Mexico  1983  410000  85  5
Panama  1985  9000  80  5-10
Paraguay  1985  12600  50  20-25
Peru  1983  94000  50  5-10
Puerto Rico  1985  23200  100  <5
St. Kitts and Nevls  1984  500  na  15
St. Vincent  and the Grenadines  1985  700  na  10
Suriname  1985  2300  95  15
Trinidad and Tobago  1983  7600  95  <5
Venezuela  1983  77000  81  5
Sub-Sahamn  Africa
Mauritius  1985  6600  100  <5
Sao Tom6 and Principe  1985  1100  na  20
Seychelles  1985  500  na  10
Middk East  and  North  Afnica
Bahrain  1985  1600  90  20
Kuwait  1985  4300  85  5
Asia
China  1985  580000  7  <5
India  1986  18000  0.2  na
Korea,  Rep. of  1985  192000  75  15
Sri Lanka  1983  96000  96  30
Thailand  1985  218000  57  50
na - not ascertained.
Note: Data for around 1970  were also used for these countries except  for Guy-
ana, Seychelles,  Sao Tome, Bahrain,  Israel, China, India, the Republic  of Korea,
and Sri Lanka. In addition, 1970  data were used for five additional  countries:
Colombia,  the Arab Republic  of Egypt, Honduras, Nicaragua,  and St. Lucia.  The
quality  indices, in ten cases, are for a later data year, either 1986  or 1987.  The
data used for China and India were sample survey data.
For each country for the first three quinquennia,  life tables are chosen  from the
Coale-Demeny  set.  The first step  is to select that  family of life tables  (North,  South,
East,  or West) for which  the ratio of life expectancy  to infant  mortality is as close as26  Estimates  and Projections  of Mortality  by Cause
possible  to the ratio for that country. The second step is to make up composite  or 'split'
life tables from life tables for different levels of the selected family: the infant mortality
rate is used to select levels to apply up to age 14, and the life expectancies  are used in
conjunction with the first selection to select levels to apply from age 15 on. By the
thirteenth quinquennium, all countries  are assumed to have reverted to West model life
tables, with levels chosen according  to the median trend in life expectancies  and infant
mortality determined entirely by  the  choice of levels. Between the  third  and  the
thirteenth quinquennium, life tables are interpolated to provide a smooth transition.
Single-year deaths by  age and  sex are obtained by interpolation from the
quinquennial estimates normally provided in the projections, taking migration into
account.
For more detail and justification  of these procedures, a background paper on the
World Bank projection procedures (Bulatao  and Bos 1989)  can be consulted.
Predicting deaths  by major cause
The equations for major causes of death show mortality rates  by cause increasing
with overall mortality for all causes except neoplasms. The increases are greatest for
infectious and parasitic diseases (slopes around 0.5, meaning that half of an increase in
deaths is attributable to this major cause), followed by other and unknown  causes
(slopes around 0.25) and perinatal conditions (slope of 0.22, for age group 0 only).
Slopes vary considerably  by age group: for infectious and parasitic diseases, they vary
from 0.7 for those 14  years old to 0.4 for those 65 and older. Slopes also vary by sex:
for neoplasms among those 65 and older, the slope for males is -0.13 and for females
-0.04. Nevertheless, the trend across age groups is essentially similar between males
and females. In contrast, slopes vary very little across regions, with the largest gap
between regions for a given cause and sex and age group being around 0.04. The
equations for lower-mortality,  more developed  regions do appear to diverge more often
from the norm, though ordy minimally. Considering the number of regions and the
rarity of even small differences in the equations, the case for distinct cause of death
structures across regions is weak.
Where reported data were not available,  the equations specific  to each of the 24
regions were applied (though the world equations would produce similar results). For
2000 and 2015, we maintained the same region-specific  equations for the industrial
market economnies  but allowed each other country to switch from its region-specific  set
of equations to the equations for developed countries as a whole if its mortality level
had declined sufficiently, as indicated by a crude death rate, standardized using the
1985  age structure for the world as a whole, below 6. (The industrial market economies
as a group have a standardized crude death rate of 5.8, as contrasted, for example, with
9.0 for Latin America and the Caribbean.)
The few negative estimates of mortality rates (e.g., because of the negative
slopes for neoplasms) were set to  zero case by  case, and  rates for other  disease
categories adjusted proportionally.Annex  A. Mehodology  27
Estimating deaths by specific  cause
To estimate new regressions  for 22 specific  causes of death, data for around 1970
and around 1985  were pooled. As noted earlier, Latin  America  and Caribbean  countries
had no data for some causes for 1985,  requiring the inclusion of 1970  data. Altogether,
1970  data for 65 countries (34  of them developing, mostly Latin  American)  and 1985  data
for 69 countries (38 developing)  were used. Because  of the number of causes for which
estimates could not be produced, the U.S.S.R. and India were excluded, but China was
included. Data quality varies for the countries included, but imposing a more rigorous
standard would bias the sample strongly toward developed countries.
For each country, mortality rates by cause were first adjusted to correspond to
overall mortality levels in the World Bank estimates and projections. Rates based on
fewer than 10,000  people in the age-sex  group were excluded. Three equations were
then estimated for each disease in each age-sex  group: a quadratic specification,  where
the rate for the specific  cause depended on the rate for the major cause and the square
of this rate, as well as on  a dummy variable for data year; a corresponding linear
specification;  and a specification  in which the rate for the specific  cause depended only
on two,  dummy variables, for developing country status and data year.
If the quadratic term achieved a 5 percent level of significance, the quadratic
equation was  chosen; if  not,  and  the  linear term  achieved a  5 percent  level of
significance,  the linear equation was chosen; and in all remaining cases, the dummy
variable equation was chosen. Of the 264 final equations, half were quadratic, a third
linear, and the remainder dummy variable  equations. The dummy vanable for data year
had a significant  effect in 20 percent of the equations chosen.
Mortality  rates for some specific  causes of death were predicted better than rates
for others. R 2 did vary much more by cause than by age-sex group, permitting the
grouping of equations by cause:
a.  mean 12 over .70: diarrhea, acute respiratory infection, other cardiovascular
diseases, and unspecified causes
b.  mean  11 between .35 and  .60: tuberculosis, measles, chronic obstructive
pulmonary disease, other infectious and parasitic diseases, cerebrovascular
disease, nephritis/cirrhosis/ulcers,  miaonutrient disorders, and malnutrition
c.  mean R 2 between .20 and .25: intestinal parasites, ischemic heart disease,
and diabetes
d.  mean  R 2 below  .20: polio,  malaria,  yellow fever/dengue/encephalitis,
schistosomiasis/filariasis,  mental disorders, and oral health diseases.
The last group also accounted for almost all the dummy variable equations. Mortality
rates for causes in this group did not covary  with mortality levels for broader categories,
and  developed or developing country averages were essentially applied for these
causes.28  Estimates  and  Projections  of Mortality  by Cause
Reclassifying deaths from unspecified  causes
The subcategory of unspecified causes of death indudes particular causes that
we cannot treat individually-meningitis,  appendicitis, kidney infections, congenital
anomalies, indirect obstetric  causes, etc.-as  well as vague and ill-defined conditions.
Particularly  for developing countries, where ill-defined conditions may be numerous
(see the  last column in Table A3), it is useful to  determine the  potential effect of
reclassifying  these deaths under other categories.
The appropriate procedure would be to use as a guide empirical studies that
reclassify under other headings deaths reported as due to ill-defined conditions. Not
having located such studies, we propose an alternative  requiring no special  information.
This alternative involves, first, determining the number of such deaths, and second,
calculating the maximum potential increase in deaths in every other category from
reclassifying  deaths from ill-defined conditions.
The deaths in the unspecified causes subcategory set an upper  limit on the
deaths we need to reclassify. We reduce the number by assuming that mortality rates
for this subcategory for developed countries reflect properly diagnosed miscellaneous
causes, and  that only rates for developing countries that  exceed these developed-
country rates reflect deaths from ill-defined  causes. The latter can thus be estimated for
each age-sex group in each developing country region.
These deaths might simply be distributed proportionally across all other cause
of  death  categories. However,  we  do  not  wish  to  exdude  the  possibility that
proportionally more  deaths  are  misdiagnosed for  some  causes  than  for others.
Therefore, we set a maximum possible increase for each category from reclassifying
deaths from ill-defined causes. These maximum increases are determined under two
assumptions: that they are proportional to the square root of p; (1- p,), where pi is the
proportion of deaths initially in category i; and that the largest possible maximum
increase for any category (by the previous assumption, this would be for a category
with exactly  half of all deaths) is the total estimated deaths from ill-defined causes.
These maximum potential increases should  total more than  the  ill-defined
deaths, and maximum  increases  for subcategories  should total more than the maximum
increase for the major category of which they are a part. This is as it should be. The
maximum increases only indicate how much larger each category  might be, but do not
indicate that it should be larger, and not all categories can simultaneously be much
larger.
Annex  B. Supplementary  Tables
The tables in this annex provide demographic  parameters by region (B1  and B2);
mortality rates and deaths for major causes by age, sex, and region from 1970  to 2015
(B3  and B4); and mortality rates and deaths for specific  causes by age, sex, and region
for 1985  (B5  and B6).  The estimates in the latter two tables are the regression estimates,
and have not incorporated expert assessments, which appear in the following  annex.Annex B. Suppkmentary  Tableo  29
Table  B1. Population  in millions by age and sex, major world  regions,  1970-2015
Regon, age  1970  1985  2000  2015
and  gax  Mak  Femal  Mae  Femae  Male  Femak  Male  Female
World
Total  1848  1853  2438  2406  3128  3075  3801  3745
0  57  53  62  59  70  68  74  71
1-4  212  201  232  222  2n  263  287  278
5-14  434  419  542  516  641  622  691  669
15-44  797  m  1117  1076  1461  1402  1746  1687
45-64  257  276  363  368  500  498  748  738
65+  92  134  122  165  183  224  256  303
Developed
Total  507  560  570  606  618  645  647  670
0  9  8  9  9  8  8  9  8
1-4  37  35  35  34  33  32  34  32
5-14  98  94  89  85  87  83  84  80
15-44  227  230  266  260  276  268  261  253
45-64  92  116  121  136  146  153  175  180
65+  44  76  51  83  67  100  84  117
Developing
Total  '  1341  1293  1868  1800  2510  2430  3154  3075
0  48  45  53  51  62  60  65  63
1-4  174  165  197  189  238  231  253  245
5-14  336  325  453  432  554  539  607  589
15-44  569  541  851  816  1185  1133  1484  1434
45-64  165  160  242  232  355  344  573  558
65+  48  58  72  81  116  123  172  186
Industral
Total  334  360  371  389  398  412  411  424
0  6  6  5  5  5  5  5  5
1-4  24  23  20  19  20  19  20  19
5-14  62  59  55  52  52  50  50  47
1C-44  146  146  174  171  176  170  160  154
45-64  65  75  79  84  98  101  116  118
65+  32  51  37  57  47  67  60  81
Nonmarket
Total  173  200  199  217  220  233  236  246
0  3  3  4  4  3  3  4  3
1-4  13  12  15  14  13  13  14  13
5-14  37  35  34  32  35  34  34  33
15-44  81  84  91  89  100  98  101  99
45-64  27  41  43  51  48  52  59  62
65+  12  25  13  27  20  33  24  36
LAC
Total  142  142  201  201  264  265  319  322
0  5  4  6  6  6  5  6  6
1-4  18  17  22  21  23  22  23  22
5-14  38  37  49  48  57  55  55  53
15-44  59  59  92  91  129  128  156  153
45-64  17  17  24  25  37  40  62  65
65+  6  7  8  10  12  1S  18  2430  Estimates  and  Projections  of Mottality by Cause
Table 8l. Population  in mlllions  (continued)
Region,  age  1970  1985  2000  2015
and  sex  Male  Female  Male  Female  Male  Female  Male  Female
Sub-Sahara
Total  146  150  226  230  358  362  539  545
0  6  6  9  9  14  14  17  17
1-4  21  21  33  33  49  49  65  64
5-14  39  39  62  62  100  99  142  140
15-44  60  62  93  94  152  153  245  246
45-64  15  16  22  24  34  37  56  60
65+  4  5  6  7  9  11  15  18
MENA
Total  128  122  193  183  293  280  411  394
0  5  5  7  7  9  9  11  10
1-4  17  17  25  24  35  34  41  39
5-14  35  33  51  47  76  74  94  91
15-44  52  50  84  78  131  123  194  185
45-64  15  14  21  20  32  31  57  53
65+  5  5  6  6  9  10  15  15
Asia
Total  924  880  1248  1186  1595  1523  1885  1815
0  33  30  31  29  33  32  32  30
1-4  118  110  117  111  131  126  125  121
5-14  225  216  291  274  321  311  316  305
15-44  398  371  583  552  774  730  890  851
45-64  117  112  175  162  251  237  397  380
65+  33  41  52  58  85  87  125  128
India
Total  286  266  395  370  519  491  631  605
o  10  9  12  11  12  11  11  11
1-4  35  32  45  43  46  45  45  43
5-14  68  65  97  92  113  110  116  112
15-44  123  115  173  161  251  234  310  298
45-64  38  34  53  47  73  70  114  105
65+  11  11  16  16  24  22  35  36
China
Total  427  402  550  515  669  629  753  714
0  15  14  10  9  12  11  11  10
1-4  54  51  37  35  47  45  43  41
5-14  101  96  117  108  116  112  108  103
15-44  188  167  275  255  324  303  331  313
45-64  55  54  86  77  125  113  195  183
65+  15  22  26  31  46  46  65  63
Other Asia
Total  211  212  303  301  407  403  502  495
0  8  7  9  9  10  9  10  9
1-4  29  27  35  33  38  37  38  36
5-14  56  56  78  74  92  89  93  90
15-44  87  88  135  136  199  194  249  239
45-64  25  24  36  37  53  54  89  92
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Table  B2. Estimnates  and  projections  of fertility,  mortality,  and  population  growth  for
major regions  in selected quinquennia
Life  expeetancy
Quinquen.  Births  Deaths  Growth  Total  -at  birth  Mortality
nium and  rate  fertility  Infant  Under  5
reglon  Crude  rate  per  1000  (percent)  rate  Males  Females (1000  qO)  (1000  q5)
1970-75
World  31  12  1.9  4.3  60  63  83  122
Developed  16  10  0.7  2.2  69  76  24  28
Developing  37  12  2.4  5.2  57  58  93  138
Industrial  16  10  0.7  2.1  71  78  15  17
Nonmarket  18  11  0.7  2.4  64  73  38  47
LAC  34  9  2.4  4.8  60  65  63  85
Sub-Sahara  48  20  2.8  6.6  43  47  138  231
MENA  42  15  2.7  6.3  52  54  116  169
Asia  35  11  2.3  4.9  59  59  84  119
1985-90
World  27  10  1.7  3.4  63  67  70  96
Developed  15  10  0.5  1.9  70  77  15  18
Developing  31  10  2.1  3.9  61  63  78  108
Industrial  13  9  0.5  1.7  73  79  9  10
Nonmarket  17  11  0.7  2.3  66  74  24  28
LAC  29  7  2.0  3.6  64  69  56  69
Sub-Sahara  46  15  3.1  6.4  50  53  111  171
MENA  40  10  3.0  5.6  59  61  90  121
Asia  27  9  1.8  3.3  63  65  68  90
2000-05
World  23  8  1.4  2.9  66  70  50  67
Developed  13  10  0.3  1.9  73  79  11  12
Developing  25  8  1.7  3.1  65  67  55  74
Industrial  12  10  0.3  1.8  75  81  7  7
Nonmarket  15  10  0.4  2.1  70  76  17  20
LAC  21  6  1.4  2.5  68  73  37  44
Sub-Sahara  40  11  2.9  5.4  55  59  83  122
MENA  32  8  2.4  4.3'  64  65  56  73
Asia  21  8  1.3  2.6  67  69  45  56
2015-20
World  20  8  1.1  2.6  68  72  40  53
Developed  13  11  0.2  2.0  73  80  10  11
Developing  21  8  1.3  2.6  67  70  43  58
Industrial  12  11  0.1  2.0  75  81  7  7
Nonmarket  14  11  0.3  2.1  71  78  14  17
LAC  18  7  1.1  2.2  70  75  29  34
Sub-Sahara  32  9  2.3  4.0  59  63  64  93
MENA  26  7  1.9  3.1  66  69  44  57
Asia  17  8  0.9  2.2  69  71  34  4232  Estimates  and  Proictions  of Mortality  by Cause
Table  B3.  Mortality  rates per  100,000 from major  auses,  by age,  sex, and  region,  1970-2015
Re8ion  1970  1985  2000  2015
and  age  Male  Femak  Male  Femade  Male  Femeak  Male  Female
All Causes
World
Total  1293  1281  1064  1004  863  802  880  776
0  9135  8647  8550  6955  5759  4581  4656  3538
1-4  1730  1845  1380  1291  444  390  362  281
5-14  222  238  165  154  118  103  104  87
15-44  384  346  270  244  222  204  201  172
45-64  1521  1024  1294  904  1097  774  1019  678
65+  7979  6847  7463  6497  6901  6048  6880  5845
Developed
Total  1054  1069  1047  1013  997  963  1161  1059
0  3477  1417  1920  1379  1392  988  1268  775
1-4  703  681  785  805  53  90  54  75
5-14  72  20  39  17  27  11  25  9
15-44  188  75  181  55  125  41  108  33
45-64  1160  605  1112  517  904  395  882  368
65+  7612  6355  7474  6015  6655  5482  6755  5471
Developing
Total  1383  1373  1070  1001  830  759  823  714
0  10169  9995  %71  7902  6341  5053  5098  3894
1-4  1952  2097  1486  1378  499  432  403  308
5-14  265  301  189  181  132  118  115  98
15-44  462  461  298  305  245  243  217  197
45-64  1723  1330  1385  1130  1177  942  1061  778
65+  8310  7503  7454  6993  7043  6511  6941  6080
Industri1
Total  1036  1021  986  950  1007  943  1173  1045
0  2275  890  1222  880  935  671  908  533
1-4  907  957  428  492  46  91  27  54
5-14  44  9  20  6  14  3  15  3
15-44  128  44  112  32  87  23  79  19
45-64  1000  480  926  399  775  298  778  293
65+  7270  5980  7084  5711  6615  5330  6408  5073
Nonmarket
Total  1089  1155  1162  1126  980  1000  1139  1082
0  5828  2452  2931  2082  2078  1461  1m  1113
1-4  319  162  1291  1239  63  89  92  103
5-14  119  39  70  35  45  22  38  16
15-44  295  128  314  99  191  72  155  55
45-64  1540  831  1455  72  1169  588  1088  513
65+  8551  7111  8593  6661  6748  5786  7606  6372
LAC
Total  1097  903  883  706  677  557  722  594
0  7886  5789  6365  5050  4244  3322  3370  2466
1-4  1039  918  749  77  314  289  137  109
5-14  173  136  107  82  67  46  55  34
15-44  348  266  246  144  173  99  150  81
45-64  1553  1068  1351  779  1083  605  993  527
65+  8132  7019  7925  6441  7052  5742  6702  5415Annex  B. Supplementary Tables  33
Table DS. Mortality rates per 100,000  (continued)
Region  1970  1985  2000  2015
and age  Male  Femak  Mak  Female  Male  Femak  Male  Femak
Sub-Sahara
Total  2163  1882  1727  1448  1196  1024  947  785
0  17653  14573  14128  11476  9935  8003  7557  5856
1-4  2774  2424  2215  1675  1094  852  925  604
5-14  679  683  439  430  306  284  238  211
15-44  838  736  654  564  517  440  406  330
45-64  2202  1746  1995  1537  1691  1315  1444  1061
65+  9108  8382  8589  7738  7905  7114  7461  6516
MlENA
Total  1563  1520  1184  1121  775  733  691  624
0  13275  12850  11330  9237  6589  5278  5150  3978
1-4  1451  1667  1554  1574  370  356  300  305
5-14  306  357  213  206  125  114  105  91
15-44  565  571  295  326  265  296  216  223
45-64  2016  1588  1429  1182  1285  1101  1157  898
65+  8947  8002  7934  7505  7400  6953  7086  6439
Asia
Total  1280  1342  963  946  784  736  833  734
0  8627  (2r:#  8552  6999  5138  4034  4047  3026
14  2017  2287  1402  1374  343  315  215  188
5-14  203  252  146  138  91  78  74  60
15-44  410  431  250  284  201  218  177  173
4564  1649  1279  1307  1118  1108  920  1004  759
-S5+  8148  7418  7191  6939  6910  6516  6899  6099
Infectlous and  Parasitic Diseases
World
Total  449  449  318  294  176  179  140  133
0  3913  3926  3537  2990  2195  1809  1629  1277
1-4  1148  1248  775  735  272  246  215  170
514  113  146  78  88  49  54  41  44
15-44  153  166  84  93  57  81  43  60
4564  332  216  262  195  118  ill  71  63
65+  1209  948  1223  928  841  741  77  619
Developed
Total  146  112  109  74  78  59  90  63
0  953  355  306  234  126  86  66  20
1-4  172  165  274  276  3  31  9  26
5-14  17  4  6  3  1  0  0  0
15-44  29  9  24  2  6  0  0  0
45-64  148  52  85  21  46  0  32  0
65+  885  606  659  366  591  367  629  363
Developing
Total  564  595  382  368  200  211  150  148
0  4453  4592  4083  3457  2471  2036  1833  1439
1-4  1359  1482  864  817  310  276  242  188
5-14  141  187  92  105  57  62  47  50
15-44  202  233  103  122  69  100  51  70
45-64  436  335  351  297  147  161  84  83
65+  1501  1404  1620  1506  986  1046  842  78034  Estimates  and Projections  of Mortality  by Cause
Table B3.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mae  Female  Male  Female  Male  Female  Male  Female
Industrlal
Total  106  85  82  66  64  47  68  38
0  341  138  55  39  0  2  0  0
1-4  187  229  37  46  5  33.  2  19
5-14  3  1  1  0  0  0  0  0
15-44  6  3  4  1  0  0  0  0
45-64  75  28  43  17  0  0  0  0
65+  736  442  700  412  556  285  477  201
Nonmarket
Total  224  159  158  88  103  79  128  106
0  2150  781  671  509  315  213  157  48
1-4  143  44  611  594  0  28  19  35
5-14  40  8  13  6  2  0  0  0
15-44  70  20  64  5  16  0  0  0
45-64  319  97  163  26  142  1  95  u
65+  1295  938  544  267  674  531  1002  729
LAC
Total  366  301  211  177  100  86  67  55
0  3962  2957  2339  2010  1402  1151  952  710
1-4  671  611  390  385  175  172  47  43
5-14  79  72  36  35  15  13  8  6
15-44  99  93  53  40  13  15  7  9
45-64  3O0  200  206  105  65  24  22  10
65+  1306  1076  1083  847  825  615  670  455
Sv'-sSahara
Total  1070  937  817  683  498  430  346  286
o  8286  6949  6473  5350  4318  3557  3095  2449
1-4  1972  1734  1564  1186  746  584  622  402
5-14  414  456  257  280  170  178  126  127
15-44  466  416  341  306  246  226  170  155
45-64  742  540  617  440  435  335  286  214
65+  1900  1828  1681  1578  1393  1337  1205  1105
MENA
Total  624  653  459  473  209  237  142  164
o  5806  5856  5034  4194  2599  2152  1859  1481
1-4  973  1147  1081  1111  215  221  164  184
5-14  160  218  109  124  52  60  38  43
15l-  256  285  94  153  74  134  43  86
45-64  584  432  280  277  195  239  116  142
65+  1594  1425  1299  1409  1088  1207  955  1010
Asia
Total  506  577  319  323  149  176  110  119
0  3603  4164  3465  2960  1852  1509  1291  992
1-4  14"'  1623  707  726  196  191  108  104
5-14  101  154  63  75  31  35  21  24
15-44  170  217  75  49  42  83  28  53
45-64  396  314  345  309  114  146  60  66
65+  1472  1404  1736  1620  953  1065  811  767Annex  B. Suppimentary Tables  35
Table B3.  MortaUty  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mak  Female  Male  Female  Mak  Female  Male  Female
Neopiasms
World
Total  95  96  108  96  108  98  128  114
0  9  8  11  8  9  9  10  9
1-4  16  18  22  20  9  9  9  9
5-14  7  7  6  6  8  8  8  8
15-44  17  21  20  22  17  20  17  21
45-64  241  216  270  215  251  217  256  219
65+  1055  738  1127  748  1009  721  1039  746
Developed
Total  167  163  203  172  182  170  213  188
0  10  5  8  8  8  8  8  7
1-4  60  66  31  35  7  9  6  7
5-14  8  4  6  4  6  4  6  3
15-44  18  18  18  17  16  13  15  11
45-64  256  193  296  196  246  178  249  172
65+  1275  831  1503  880  1096  797  1091  800
Developing
Total  68  68  78  70  90  79  1ll  98
0  9  8  11  8  10  9  10  9
1-4  7  8  20  18  9  9  9  9
5-14  6  7  6  6  8  9  8  9
15-44  16  22  20  23  17  22  17  23
45-64  233  232  257  226  252  234  257  234
65+  857  614  862  613  958  658  1013  712
Industrw
Total  186  169  240  192  196  171  236  200
0  10  4  6  6  7  7  7  6
1-4  82  92  45  52  6  8  4  6
5-14  7  2  4  1  4  2  4  2
15-44  16  12  15  10  14  8  13  7
45-64  250  172  309  178  247  153  249  152
65+  1337  882  1679  1030  1109  814  1123  824
Nonmarket
Total  129  152  136  135  158  169  173  168
0  11  8  10  9  10  9  10  9
1-4  17  16  11  12  9  9  9  10
5-14  10  9  9  8  9  8  8  6
19-.4  22  29  25  30  19  22  18  18
S5-64  271  232  272  225  244  226  248  211
65+  1103  727  998  560  1067  764  1012  744
LAC
Total  79  76  76  70  94  86  122  109
0  8  7  9  8  10  9  10  9
1-4  14  12  9  9  10  10  10  9
5-14  6  6  7  7  9  9  9  9
15-44  16  22  15  19  18  20  17  19
45-64  221  222  223  204  265  219  268  210
65+  1021  m  998  702  1032  728  1063  75836  Estimates  and  Projections  of Mortality  by Cause
Table B3.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mak  Femak  Mak  Femak  Male  Female  Male  Female
Sub-Sahara
Total  52  57  52  55  54  55  60  60
0  9  3  9  8  9  9  10  9
1-4  5  7  6  8  8  9  8  9
5-14  2  5  5  7  6  8  7  9
15-44  12  24  14  23  16  23  17  22
45-64  213  236  222  235  234  234  244  233
65+  796  569  833  593  882  617  914  640
MENA
Total  60  56  65  60  69  62  81  70
0  8  7  9  9  10  9  10  9
14  7  7  7  8  10  10  10  10
5-14  6  7  7  8  8  9  9  9
15-44  18  23  18  22  18  22  18  22
45-64  206  212  244  234  251  233  257  232
65+  737  510  925  625  956  644  979  664
Asia
Total  70  70  85  74  101  87  130  113
0  10  9  13  8  10  9  10  9
14  6  7  29  25  10  10  9  9
5-14  7  8  5  6  9  9  8  9
15-44  17  22  22  24  17  22  17  24
45-64  241  235  268  227  253  236  258  238
65+  852  605  837  599  956  653  1021  719
Circulatoy System and C=tidn Degenerative  Diseases
World
Total  297  324  262  286  292  283  339  314
0  124  121  99  82  62  45  42  26
1-4  33  35  25  22  8  7  7  5
5-14  14  15  10  9  7  6  6  5
15-44  54  46  41  34  38  31  37  29
45-64  579  372  488  318  494  299  481  275
65+  3798  3396  3364  3245  3376  3070  3437  3108
Developed
Total  463  552  473  563  486  536  575  597
0  40  9  26  19  0  0  0  0
14  19  21  11  17  1  2  1  1
5-14  4  1  1  1  1  0  1  0
15-44  40  17  32  11  30  11  28  9
45-64  530  253  506  216  443  169  440  157
65+  4170  3691  4064  3793  3485  3225  3507  3234
Developing
Total  234  225  198  192  244  216  291  252
0  139  142  111  93  71  51  47  30
14  36  38  28  23  9  8  7  6
5-14  17  19  11  10  8  7  7  6
15-44  60  58  44  41  40  35  39  32
45-64  606  459  479  377  516  357  494  314
65+  3462  3005  2872  2682  3313  2943  3402  3028Annex B. Suppkmentary  Tables  37
Table B3.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mae  Fenmal  Mal  Female  Male  Femal  Male  Female
Induswtrial
Total  500  567  461  518  513  551  615  639
0  30  11  34  25  0  0  0  0
1-4  26  29  17  26  1  2  0  1
5-14  2  1  1  0  0  0  0  0
15-44  29  10  22  6  21  6  19  5
45-64  502  203  417  142  410  123  412  121
65+  4193  3754  3689  3394  3501  3258  3466  3228
Nonmarket
Total  392  524  495  644  437  509  505  526
0  60  5  14  11  0  0  0  0
1-4  7  4  2  4  1  2  2  2
5-14  7  3  2  2  3  1  2  1
15-44  58  31  51  19  47  20  42  16
45-64  595  343  670  338  510  260  497  225
65+  4105  3562  5140  4642  3447  3159  3610  3247
LAC
Total  238  214  228  196  242  215  306  275
0  81  55  79  63  27  14  12  3
1-4  20  16  14  14  6  5  3  2
5-14  9  8  6  6  4  3  3  2
15-44  50  39  40  26  35  20  34  18
45-64  561  376  554  312  517  259  497  228
65+  3468  3116  3449  2960  3470  3002  3424  3028
Sub-Sahara
Total  243  226  209  191  182  169  180  162
0  291  236  221  173  138  102  90  59
1-4  51  44  41  30  20  16  17  11
5-14  42  41  27  26  19  17  15  13
15-44  90  83  75  67  64  54  55  44
45-64  677  580  648  524  602  463  565  394
65+  3654  3135  3562  3047  3430  2948  3348  2860
MENA
Total  250  224  200  183  191  171  209  176
0  192  191  166  128  72  49  44  26
1-4  26  30  29  29  7  6  6  6
5-14  24  27  13  12  8  7  7  5
15-44  78  81  45  43  43  41  38  34
45-64  669  552  563  421  540  398  522  343
65+  3498  2909  3518  3089  3419  3013  3365  2942
Asia
Total  230  227  191  194  268  235  338  292
0  111  128  71  64  50  36  31  19
1-4  37  41  26  22  6  6  4  3
5-14  13  15  8  7  6  5  4  4
15-4  55  53  40  39  36  33  36  31
45-64  596  443  438  360  501  351  479  312
65+  3431  2982  2625  2546  3267  2924  3410  306338  Estimates  and Projections  of Mortality  by Cause
Table 83. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Femae  Male  Femae  Male  Female  Male  Female
Complications  of Pregnancy
World
Total  0  13  0  9  0  9  0  7
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  30  0  20  0  18  0  15
45-64  0  4  0  2  0  3  0  3
65+  0  0  0  0  0  0  0  0
Developed
Total  0  2  0  1  0  1  0  1
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  4  0  3  0  2  0  1
45-64  0  1  0  1  0  1  0  1
65+  0  0  0  0  0  0  0  0
Developing
Total  0  18  0  12  0  11  0  9
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  41  0  26  0  21  0  17
45-64  0  6  0  2  0  4  0  3
65+  0  0  0  0  0  0  0  0
Industrial
Total  0  0  0  .0  0  0  0  0
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-"4  0  1  0  0  0  1  0  0
45-64  0  0  0  0  0  1  0  1
65+  0  0  0  0  0  0  0  0
Nonmarket
Total  0  4  0  3  0  2  0  2
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  9  0  7  0  5  0  3
45-64  0  2  0  2  0  2  0  2
65+  0  0  0  0  0  0  0  0
LAC
Total  0  12  0  6  0  4  0  3
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  27  0  13  0  8  0  6
45-64  0  4  0  2  0  2  0  2
65+  0  0  0  0  0  0  0  0Annex B. Supplmentary Tables  39
Table B3.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Female  Mak  Femak  Mak  Femak  Mak  Femak
Sub-Sahara
Total  0  27  0  21  0  17  0  14
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  64  0  49  0  38  0  29
45-64  0  8  0  7  0  6  0  5
65+  0  0  0  0  0  0  0  0
MENA
Total  0  21  0  13  0  12  0  10
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  49  0  29  0  26  0  20
45-64  0  8  0  5  0  5  0  4
65+  0  0  0  0  0  0  0  0
Asia
Total  0  17  0  11  0  10  0  8
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  38  0  24  0  19  0  15
45-64  0  6  0  2  0  4  0  3
65+  0  0  0  0  0  0  0  0
Certin  Peinat  Condtions
World
Total  86  70  79  59  48  36  37  27
0  2778  2421  3095  2375  2129  1632  1889  1396
1-4  1  1  1  1  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Developed
Total  26  10  15  10  13  9  13  7
0  1511  647  940  656  1004  705  976  616
1-4  0  1  5  4  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Developing
Total  109  96  98  75  56  43  42  31
0  3009  2752  3459  2667  2279  1753  2009  1496
1-4  1  1  1  1  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  040  ESWmata and Projections  of Mortali4y by Cause
Table  3.  Mortaity  rates per 100,000  (continued)
Rclon  1970  1985  2000  2015
and  4e  Male  Female  Mal  Femal  Male  Fcmale  Male  Femalk
Industral
Total  21  7  8  5  10  6  10  5
0  1201  451  551  387  798  558  785  463
1-4  0  1  7  5  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Nonmarket
Total  37  15  28  17  20  13  19  11
0  2117  1030  1505  1035  1313  924  1243  828
1-4  0  0  1  2  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-4  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
LAC
Toud  61  42  65  44  40  28  30  20
0  1870  1314  2223  1572  1817  1369  1629  1175
1-4  1  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Sub-Sahara
Total  200  157  167  129  119  90  82  61
0  4734  3843  3970  3165  3062  2406  2547  1936
1-4  2  2  1  1  1  1  1  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
bMA
Total  140  126  120  97  73  57  52  39
0  3668  3350  3360  2672  2336  1808  2023  1520
1-4  1  1  1  1  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-4  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Asia
Total  98  91  88  67  42  32  30  22
0  2749  2654  3558  2719  2017  1527  1778  1300
1-4  1  2  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0Annex B. Suppkmentary  Tablks  41
Table B3. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Female  Male  Female  Male  Female  Male  Female
Injury and Poisonng
World
Total  93  40  97  56  78  31  79  32
0  108  97  142  114  83  66  74  58
1-4  100  86  209  171  45  34  43  31
5-14  31  14  32  17  24  11  23  10
15-44  100  22  86  37  82  20  79  19
45-64  124  32  110  47  109  29  106  29
65+  217  153  209  157  201  144  205  151
Developed
Total  99  51  87  40  77  37  80  39
0  82  36  52  37  42  31  41  27
1-4  263  223  136  130  30  28  26  23
5-14  27  6  16  5  13  4  13  4
15-44  78  15  79  14  62  10  58  8
45-64  103  30  97  27  97  23  96  22
65+  226  176  200  142  209  163  210  164
Developing
Total,  91  35  100  62  78  29  79  30
0  113  108  157  127  88  71  79  61
1-4  65  56  222  178  47  35  45  32
5-14  33  16  35  19  25  12  24  11
15-44.  109  25  88  44  86  23  82  21
45-64  136  33  117  58  113  31  108  31
65+  208  122  216  171  197  128  202  142
Industrial
Total  98  58  74  40  70  36  74  40
0  79  30  41  28  34  24  33  20
1-4  368  316  168  170  25  26  17  18
5-14  24  3  11  2  8  2  9  2
15-44  63  11  58  10  49  7  45  6
45-64  89  28  78  24  87  19  87  19
65+  225  187  195  150  210  167  209  168
Nonmarket
Total  100  40  109  39  90  38  90  37
0  88  48  69  50  54  40  51  36
1-4  64  49  89  75  38  30  39  31
5-14  32  11  26  10  21  8  19  7
15-44  105  20  119  21  86  15  78  12
45-64  137  33  133  32  118  30  115  28
65+  230  155  214  125  208  155  213  156
LAC
Total  98  31  90  29  76  28  78  29
0  74  56  88  73  72  57  65  49
1-4  67  45  49  37  46  34  43  30
5-14  32  13  27  13  22  10  21  10
15-44  119  24  103  21  83  20  76  17
45-64  157  35  153  32  113  29  108  28
65+  258  133  259  132  205  145  203  15242  Estimates  and  Projections  of Mortality  by Cause
Table 83. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Female  Male  Female  Male  Female  Male  Female
Sub-Sahara
Total  108  39  96  34  86  30  82  28
0  174  150  147  125  115  96  97  78
1-4  74  60  67  51  54  41  52  38
5-14  50  22  39  18  33  15  30  14
15-44  133  26  120  25  111  24  103  23
45-64  149  33  143  32  133  32  125  32
65+  210  118  206  119  202  120  199  121
MENA
Total  90  37  80  32  75  28  76  28
0  130  126  126  106  90  73  79  62
1-4  54  47  59  50  46  34  46  34
5-14  36  19  29  14  25  12  25  12
15-44  113  30  94  23  92  23  86  23
45-64  135  34  124  32  120  32  116  31
65+  197  110  206  129  201  128  200  129
Asia
Total  87  34  105  78  77  29  79  31
0  104  105  181  143  79  63  70  54
1-4  65  59  334  272  45  34  42  29
5-14  29  15  37  21  23  11  22  10
15-44  104  24  79  55  81  23  77  21
45-64  131  32  108  69  110  31  105  31
65+  200  122  211  189  195  126  202  145
Ote  Causes
World
Total  273  289  201  204  161  167  157  150
0  2204  2075  1666  1386  1280  1019  1013  m
1-4  432  457  349  342  109  93  88  66
5-14  57  57  39  35  29  24  26  20
15-44  60  61  39  39  29  34  25  28
45-64  245  186  163  128  126  115  105  90
65+  1700  1612  1539  1419  1473  1373  1428  122
Developed
Total  153  180  161  154  160  152  191  163
0  881  365  587  425  213  159  177  105
1-4  190  206  329  344  12  21  12  17
5-14  16  5  10  4  5  2  5  1
15-44  23  12  28  8  11  4  8  3
45-64  124  76  128  57  72  24  65  16
65+  1057  1051  1047  834  1273  929  1317  911
Developing
Total  318  336  213  221  162  171  150  147
0  2446  2394  1849  1550  1422  1133  1122  858
1-4  484  511  352  341  123  103  99  73
5-14  69  72  45  41  33  27  29  22
15-44  75  82  42  48  33  41  28  33
45-64  312  266  181  169  149  156  118  113
65+  2282  2358  1884  2020  1589  1736  1482  1417Annex B. Supplementary  Tables  43
Table B3.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Femal  Male  Femalk  Male  Femae  Male  Female
Industdil
Total  125  135  120  128  154  131  171  123
0  614  255  535  395  97  80  82  43
1-4  244  289  154  193  10  21  4  11
5-14  8  2  4  1  2  0  2  0
15-44  14  7  14  4  3  1  2  1
45-64  84  49  80  38  31  1  30  0
65+  779  715  821  725  1239  806  1133  653
Nonmarket
Total  209  260  237  200  172  189  225  231
0  1402  580  663  467  386  276  311  192
1-4  87  49  577  553  15  21  23  25
5-14  29  9  20  9  11  4  9  3
15-44  40  20  55  16  24  9  17  6
45-64  218  124  217  89  155  69  133  47
65+  1819  1729  16%  1066  1352  1177  1769  1495
LAC
Total  255  227  213  184  124  111  119  102
0  1891  1400  1627  1323  915  723  703  518
1-4  265  234  286  273  78  69  34  26
5-14  47  38  31  22  17  10  13  7
15-44  63  61  36  26  22  16  16  12
45-64  306  232  215  125  123  71  97  50
65+  2078  1921  2135  1799  1520  1253  1342  1022
Sub-Sahara
Total  491  438  386  334  258  233  1%  174
0  4159  3388  3306  2655  2292  1833  1718  1324
1-4  670  577  536  399  266  203  225  144
5-14  171  158  111  100  77  66  60  49
15-4  135  123  104  94  80  74  61  56
45-64  420  350  366  299  287  245  223  184
65+  2548  2732  2307  2401  1997  2091  1795  1790
MENA
Total  400  404  260  263  157  166  131  137
0  3470  3320  2636  2129  1483  1187  1135  879
1-4  391  435  377  376  92  85  75  73
5-14  80  87  54  48  32  26  26  21
15-44  100  103  44  55  39  50  30  38
45-64  422  350  218  214  180  194  146  145
65+  2921  3048  1986  2253  1736  1960  1587  1695
Asia
Total  289  327  175  199  147  167  145  149
0  2051  2199  1265  1105  1131  890  867  651
1-4  498  555  307  329  85  75  53  44
5-14  53  60  32  29  23  18  18  13
15-44  64  76  33  43  24  37  20  29
45-64  286  249  148  152  130  151  102  109
65+  2193  2305  1783  1985  1539  1748  1454  140544  Estimates  and Projetions  of Mortality  by Cause
Table  84. MotalIty  rates  per 100,000 from major c  .s,  by age, sexc,  and  region,  1970-
2015  _
Region  1970  1985  2000  2015
and  age  Malc  Female  Male  Female  Male  Femak  Male  Female
All Causes
World
Total  23778  23614  25842  24057  26900  24576  33323  28950
0  5205  4607  5282  4111  4035  3092  3431  2512
1-4  3630  3666  3186  2854  1202  1022  1036  779
5-14  962  995  892  795  753  642  720  584
15-44  3052  2659  3011  2627  3247  2855  3499  2902
45-64  3875  2808  4666  3307  5461  3834  7582  4983
65+  7053  8878  8806  10363  12203  13129  17055  17190
Developed
Total  5323  5953  5941  6106  6132  6181  7470  7053
0  306  119  171  118  115  77  108  63
1-4  262  241  274  269  18  29  18  24
5-14  71  19  35  14  23  9  21  7
15-44  427  171  481  143  344  109  283  83
45-64  1063  699  1340  700  1313  604  1540  661
65+  3194  4704  3640  4862  4319  5354  5501  6216
Developing
Total  18455  17661  19901  '17951  20769  18394  25853  21896
0  4899  4488  5111  3993  3920  3015  3323  2449
1-4  3369  3425  2913  2585  1184  994  1018  755
5-14  891  976  857  781  730  633  699  578
15-44  2625  2488  2529  2485  2902  2746  3216  2818
45-64  2813  2109  3326  2607  4148  3230  6042  4323
65+  3859  4174  5165  5501  7884  7775  11555  10974
Industrial
Total  3448  3657  3640  3672  3988  3864  4795  4410
0  132  49  65  44  46  32  45  25
1-4  221  221  88  96  9  17  5  10
5-14  27  5  11  3  7  2  8  2
15-44  187  64  195  54  153  38  126  29
45-64  644  358  723  335  757  301  902  346
65+  2236  2960  2558  3140  3015  3474  3709  3998
Nonmarket
otal  1875  2296  2301  2434  2144  2318  2675  2643
0  173  69  107  74  68  46  63  38
1-4  41  20  186  174  8  11  13  14
5-14  44  14  24  11  16  7  13  5
15-44  240  107  286  88  192  70  156  54
45-64  419  342  616  365  555  303  638  315
65+  958  1744  1082  1722  1304  1880  1792  2217
LAC
Total  1557  1274  1768  1416  1778  1474  2294  1907
0  365  259  370  285  243  183  195  137
1-4  185  159  163  152  72  64  31  24
5-14  65  50  52  39  38  25  30  18
15-44  205  156  226  132  222  126  233  124
45-64  265  184  326  197  403  239  610  341
65+  4n  466  631  611  800  837  11%  1264Annex  B. Supplmentary  Tables  45
Tablo  4.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mae  Female  Mal  Femae  Mae  Femae  Mak  Female
Sub-Sahara
Total  313B  2796  3885  3318  4257  3697  5093  4264
0  1078  884  1337  1072  1370  1084  1309  994
1-4  583  505  733  551  536  414  595  385
5-14  263  266  273  267  305  281  337  ?46
15-44  501  455  603  531  781  670  991  809
45-64  336  281  444  368  568  482  807  631
65+  376  405  495  529  697  767  1053  1149
MtENA
Total  1993  1843  2272  2042  2264  2046  2831  2454
0  644  586  778  610  605  465  543  402
1-4  252  274  387  373  128  119  122  119
5-14  107  117  107  97  95  84  98  82
15-44  291  282  246  255  347  362  418  413
45-64  292  215  291  238  412  339  658  477
65+  407  370  462  468  677  676  992  960
Asia
Total  11768  11747  11976  11175  12469  11177  15634  13272
0  2811  2759  2626  2025  1702  1284  1277  916
1-4  2349  2487  1630  1510  448  397  270  227
5-14  456  544  424  378  291  243  233  181
15-44  1628  1595  1454  1567  1553  1588  1574  1473
45-64  1920  1429  2265  1804  2766  2171  3967  2874
65+  2604  2933  3577  3892  sno  5495  8313  7600
Infecdous and Parasitic  Diseases
World
Total  8255  8280  7725  7039  5491  5495  5300  4957
0  2229  2092  2185  1767  1538  1221  1200  907
1-4  2409  2479  1788  1624  737  646  615  470
5-14  490  610  422  456  316  336  285  293
15-44  1213  1278  942  998  828  1133  755  1007
45-64  846  591  945  713  585  552  531  460
65+  1068  1230  1444  1480  1487  1608  1914  1819
Developed
Totd  737  621  616  444  479  376  577  422
0  84  30  27  20  10  7  6  2
1-4  64  58  96  92  1  10  3  8
5-14  17  3  5  2  1  0  0  0
15-44  66  21  65  6  16  0  0  0
45-64  135  61  102  28  67  1  56  0
65+  371  449  321  295  384  358  512  412
Developing
Total  7518  7658  7109  6595  5013  5119  4723  4535
0  2145  2062  2158  1747  1528  1215  1195  905
1-4  2345  2421  1693  1532  736  636  612  462
5-14  473  607  417  454  315  336  285  293
15-44  1147  1257  877  992  812  1133  755  1007
45-64  711  531  842  685  518  551  476  460
65+  697  781  1122  1185  1103  1249  1401  140846  Estimates  and Projectionj  of Mortality  by Cause
Table B4. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Femae  Male  Femae  Mal  Female  Mak  Femae
Industrl
Total  351  305  303  255  254  192  277  162
0  20.  8  3  2  0  0  0  0
1-4  45  53  8  9  1  6  0  4
5-14  2  1  1  0  0  0  0  0
15-44  9  4  6  2  0  0  0  0
45-64  48  21  33  15  0  0  0  0
65+  226  219  253  226  253  186  276  158
Nonmarket
Total  386  316  313  190  224  183  300  260
0  64  22  24  18  10  7  6  2
1-4  18  5  88  83  0  4  3  5
5-14  15  3  5  2  1  0  0  0
15-44  57  16  58  4  16  0  0  0
45-64  87  40  69  13  67  1  56  0
65+  145  230  69  69  130  173  236  254
LAC
Total  519  425  423  355  264  226  213  178
0  184  132  136  113  80  63  55  39
14  119  106  85  81  40  38  11  9
5-14  29  27  18  17  8  7  4  3
15-44  59  55  48  37  17  19  10  14
45-64  53  35  50  27  24  10  14  6
65+  76  71  86  80  94  90  120  106
Sub-Sahara
Total  1552  1393  1838  1565  im  1552  1860  1553
0  506  422  613  500  595  482  536  416
1-4  415  361  518  390  365  283  400  256
5-14  161  177  160  173  170  176  178  178
15-44  279  257  314  288  373  345  416  381
45-64  113  87  137  105  146  123  160  127
65+  78  88  97  108  123  144  170  195
MENA
Total  795  792  881  862  611  662  582  646
0  282  267  346  277  239  190  196  150
1-4  169  189  269  263  75  74  66  72
5-14  56  71  55  59  40  44  36  39
15-44  132  141  78  120  9  164  84  160
45-64  85  58  57  56  63  74  66  75
65+  73  66  76  88  100  117  134  151
Asia
Total  4651  5048  3967  3813  2366  2678  2067  2158
0  1174  1241  1064  857  613  480  407  300
1-4  1642  1765  821  798  256  241  135  125
5-14  227  332  184  205  98  108  67  73
15-44  677  804  436  547  326  606  245  453
45-6  461  351  599  498  285  345  236  252
65+  470  555  864  909  788  898  978  956Annae B. Supplmentary Tables  47
Table 84. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mak  Femak  Mak  Femake  Male  Female  Mak  Femak
Neoplasms
World
Total  1750  1778  2610  2293  3361  3005  4854  4245
0  5  4  7  5  7  6  7  6
1-4  34  36  50  45  25  24  26  24
5-14  29  28  31  30  51  52  55  54
15-44  134  163  220  234  247  284  291  358
45-64  615  591  973  785  1248  1073  1901  Uo08
65+  933  956  1330  1193  1784  1565  2575  2194
Developed
Total  842  907  1154  1036  1121  1093  1370  1253
0  1  0  1  1  1  1  1  1
1-4  22  23  11  12  2  3  2  2
5-14  8  4  5  3  5  3  5  3
15-44  41  41  49  44  43  36  39  29
45-64  234  223  356  265  358  271  435  309
65+  535  615  732  711  712  779  888  909
Developing
Total  908  871  1456  1257  2240  1912  3484  2993
0  4  4  6  4  6  5  6  6
14  12  12  39  33  22  22  23  22
5-14  22  24  26  27  45  49  50  52
15-44  92  121  171  189  204  248  252  329
45-64  380  368  617  521  890  802  1466  1299
65+  398  341  598  482  1073  786  1686  1285
Industral
Total  620  604  885  744  775  702  963  842
0  1  0  0  0  0  0  0  0
1-4  20  21  9  10  1  2  1  1
5-14  4  1  2  1  2  1  2  1
15-44  24  17  27  17  25  14  21  11
45-64  161  128  241  149  242  155  289  179
65+  411  437  606  566  505  531  650  649
Nonmarket
Total  221  303  268  292  346  391  406  411
0  0  0  0  0  0  0  0  0
1-4  2  2  2  2  1  1  1  1
5-14  4  3  3  3  3  3  3  2
15-44  18  24  22  27  19  22  18  18
45-64  74  95  115  115  116  116  146  130
65+  124  178  126  145  206  248  238  259
LAC
Total  112  107  153  141  247  226  389  349
0  0  0  1  0  1  1  1  1
1-4  3  2  2  2  2  2  2  2
5-14  2  2  3  3  5  5  5  5
15-44  9  13  14  17  24  26  27  29
45-64  38  38  54  51  99  87  164  136
65+  59  51  79  67  117  106  190  17748  .taes  and Projetin  of Modali  by Caue
Table E4. Mortaity rates per 100,000  (contnued)
Region  1970  1985  2000  2015
and  age  Male  Femae  Mak  Femal  Mal  Femal  Mak  Female
Sub-Sahara
Total  75  84  116  126  192  200  324  325
0  1  0  1  1  1  1  2  2
1-4  1  1  2  3  4  4  5  6
5-14  1  2  3  4  6  8  10  12
15-44  7  15  13  22  24  34  41  55
45-64  33  38  49  56  79  86  137  138
65+  33  27  48  41  78  67  129  113
MENA
Total  76  67  125  110  202  172  331  277
0  0  0  1  1  1  1  1  1
1-4  1  1  2  2  3  3  4  4
5-14  2  2  4  4  6  7  8  8
15-44  9  11  15  17  24  27  35  41
45-64  30  29  50  47  80  72  146  123
65+  34  24  54  39  87  63  137  99
Asia
Total  646  613  1063  880  1599  1313  2440  2042
0  3  3  4  2  3  3  3  3
1-4  7  8  33  27  13  12  12  10
5-14  17  17  16  15  28  29  27  27
15-44  66  83  130  133  133  161  149  205
45-64  280  263  464  366  632  558  1019  901
65+  272  239  416  336  790  550  1230  896
Circaor  System and Certa  Degeneratve Diseae
World
Total  5464  5970  6362  6846  9101  8662  12843  11714
0  71  64  61  48  44  30  .31  19
1-4  69  69  58  49  22  19  19  14
5-14  61  61  52  45  46  39  44  35
15-44  432  352  461  365  557  429  648  482
45-64  1475  1019  1761  1163  2461  1482  3580  2025
65+  3357  4404  3970  5176  5970  6664  8520  9140
Developed
Total  2339  3074  2681  3394  2990  3439  3699  3978
0  4  1  2  2  0  0  0  0
1-4  7  7  4  6  0  1  0  0
5-14  4  1  1  1  1  0  1  0
15-44  90  40  85  27  84  30  72  23
45-64  485  292  609  293  643  259  769  281
65+  1750  2732  1979  3066  2262  3150  2856  3674
Developing
Total  3124  2897  3681  3452  6111  5223  9144  7736
0  67  64  59  47  44  30  31  19
1-4  62  62  54  44  22  18  19  14
5-14  56  60  51  44  45  38  43  34
15-44  342  312  376  337  473  399  576  459
45-64  989  727  1151  870  1818  1223  2812  1744
65+  1608  1672  1990  2110  3709  3514  5664  5466Anna  B. Suppementary  Tables  49
Table R4.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mak  Female  Male  Female  Mak  Femak  Male  Female
Industriat
Total  1665  2032  1702  2002  2033  2258  2514  2694
0  2  1  2  1  0  0  0  0
1-4  6  7  3  5  0  0  0  0
5-14  1  0  1  0  0  0  0  0
15-44  43  15  38  10  37  10  30  7
45-64  323  151  326  119  400  125  477  143
65+  1290  1858  1332  1866  1595  2123  2006  2544
Nonmarket
Total  674  1042  979  1392  957  1181  1185  1284
0  2  0  1  0  0  0  0  0
1-4  1  0  0  1  0  0  0  0
5-14  3  1  1  1  1  0  1  0
15-44  47  26  47  17  47  20  42  15
45-64  162  141  284  173  242  134  292  138
65+  460  874  647  1200  666  1026  850  1130
LAC
Total  337  303  456  393  636  569  972  883
O  4  2  5  4  2  1  1  0
1-4  4  3  3  3  1  1  1  0
5-14  4  3  3  3  2  2  2  1
15-44  30  23  37  24  45  25  53  27
45-64  96  65  134  79  192  102  305  147
65+  201  207  275  231  394  438  611  707
Sub-Sahara
Total  353  336  470  439  648  609  970  881
0  18  14  21  16  19  14  16  10
1-4  11  9  13  10  10  8  11  7
5-14  16  16  17  16  19  17  21  18
15-44  54  52  69  63  96  83  134  107
45-64  103  93  144  125  202  169  316  234
65+  151  152  205  208  302  318  473  504
M1ENA
Total  319  271  383  333  557  477  855  693
0  9  9  11  8  7  4  5  3
1-4  5  5  7  7  2  2  2  2
5-14  8  9  7  6  6  5  6  5
15-44  40  40  38  34  56  50  74  62
45-64  97  75  115  85  173  123  297  182
65+  159  134  205  193  313  293  471  439
Asia
Total  2115  1987  2373  2288  4269  3569  6348  5279
0  36  38  22  19  17  11  10  6
1-4  43  45  31  24  8  7  5  4
5-14  28  33  24  19  18  15  14  11
15-44  218  197  232  217  276  241  316  263
45-64  694  495  759  581  1251  829  1893  1180
65+  1097  1179  1306  1428  2700  2466  4109  381650  Estimates  and Projections  of Mortality  by Cause
Table 94. Mortality  rates per 100,000  (continued)
Regin  1970  1985  2000  2015
and  age  Male  Female  Mak  Female  Mal  Female  Male  Female
CompliatUo.s of Pregnancy
World
Total  0  239  0  225  0  265  0  269
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  1  0  0  0  0  0  0
15-44  0  229  0  218  0  249  0  249
45-64  0  10  0  7  0  16  0  20
65+  0  0  0  0  0  0  0  0
Developed
Total  0  10  0  8  0  7  0  5
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  9  0  7  0  6  0  4
45-64  0  1  0  1  0  2  0  2
65+  0  0  0  0  0  0  0  0
Developing
Total  0  229  0  218  0  257  0  263
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  1  0  0  0  0  0  0
15-44  0  220  0  212  0  243  0  245
45-64  0  9  0  6  0  14  0  18
65+  0  0  0  0  0  0  0  0
Industrlal
Total  0  2  0  0  0  2  0  1
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  2  0  0  0  1  0  1
45-64  0  0  0  0  0  1  0  1
65+  0  0  0  0  0  0  0  0
Nonmarket
Total  0  9  0  7  0  6  0  4
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  8  0  6  0  5  0  3
45-64  0  1  0  1  0  1  0  1
65+  0  0  0  0  0  0  0  0
LAC
Total  0  16  0  12  0  12  0  11
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  16  0  12  0  11  0  10
45-64  0  1  0  1  0  1  0  1
65+  0  0  0  0  0  0  0  0Annca B. Supplementary  Tables  5s
Table B4.  MortalIty  rates per 100,000  (continued)
RegIn  1970  1985  2000  2015
and  age  male  Feme  Mak  Female  Mak  Female  Mak  Femak
Sub-Sahara
Total  0  41  0  48  0  61  0  74
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  39  0  46  0  59  0  71
45-64  0  1  0  2  0  2  0  3
65+  0  0  0  0  0  0  0  0
MENA
Total  0  25  0  23  0  33  0  39
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  24  0  22  0  32  0  37
45-64  0  1  0  1  0  2  0  2
65+  0  0  0  0  0  0  0  0
Asia
Total  0  147  0  134  0  151  0  139
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  141  0  131  0  142  0  127
45-64  0  6  0  3  0  9  0  12
65+  0  0  0  0  0  0  0  0
Certain Perimatal  Condito_
World
Total  1585  1292  1915  1406  1492  1102  1393  992
0  1582  1290  1912  1404  1492  1102  1392  991
1-4  2  3  3  2  1  1  1  1
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Developed
Total  133  54  86  58  83  55  83  50
0  133  54  84  56  83  55  83  50
1-4  0  0  2  1  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Developing
Total  1452  1238  1829  1349  1410  1047  1310  942
0  1450  1236  1828  1348  1409  1046  1309  941
1-4  2  2  1  1  1  1  1  1
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  052  Estimtes and  Projections  of  Mortality  by Cause
Table  EUL  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  FemakF  Ma  Femal  Mle  Female  Male  Femal
Industrial
Total  70  25  31  20  39  26  39  22
0  70  25  29  19  39  26  39  22
1-4  0  0  1  1  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Nonmarket
Total  63  29  55  37  43  29  44  28
0  63  29  55  37  43  29  44  28
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
LAC
Total  87  59  129  89  104  75  94  65
0  87  59  129  89  104  75  94  65
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Sub-Sahara
Total  290  233  376  296  423  326  442  329
0  289  233  376  296  422  326  441  329
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-6  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
MlENA
Total  178  153  231  177  214  159  213  154
0  178  153  231  177  214  159  213  154
1-4  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0
Asia
Total  897  793  1093  787  668  486  561  394
0  896  791  1092  787  668  486  561  394
1-4  1  2  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0Annex  B. Supplemeniary  Tables  53
Table B4.  Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Mak1  Female  Mae  Femalt  Male  Female  Mal  Female
Injury an  Poisonin8
World
Total  1713  734  2345  1349  2423  938  2999  1176
0  61  52  88  67  58  45  55  41
1-4  210  171  482  378  122  90  123  86
5-14  136  57  174  86  153  68  158  69
15-44  798  169  956  398  1194  282  1371  326
45-64  316  87  398  170  540  141  786  211
65+  191  199  247  250  35X,  313  507  443
Developed
Total  498  286  491  238  473  235  513  259
0  7  3  5  3  3  2  3  2
1-4  98  79  47  43  10  9  9  8
5-14  26  6  15  4  12  4  11  3
15-44  177  33  209  36  171  26  151  21
45-64  94  35  117  36  141  35  168  39
65+  95  131  98  115  136  159  171  187
Developing
Total  1215  448  1854  1110  1950  704  2486  916
0  54  49  83  64  54  42  51  39
1-4  112  92  435  335  112  81  114  78
5-14  109  51  159  81  141  64  147  66
15-44  620  136  747  362  1023  256  1220  305
45-64  222  52  281  134  399  107  618  172
65+  97  68  149  135  220  153  336  257
Industrial
Total  326  207  274  155  277  146  303  168
0  5  2  2  1  2  1  2  1
1-4  90  73  34  33  5  5  3  3
5-14  15  2  6  1  4  1  4  1
15-44  92  16  101  17  85  11  72  9
45-64  57  21  61  20  85  19  101  22
65+  69  93  71  83  96  109  121  132
Nonmarket
Total  171  80  216  83  196  89  210  91
0  3  1  3  2  2  1  2  1
1-4  8  6  13  10  5  4  5  4
5-14  12  4  9  3  7  3  7  2
15-44  86  17  109  19  86  15  79  12
45-64  37  14  56  16  56  15  67  17
65+  26  38  27  32  40  50  50  54
LAC
Total  139  44  181  58  199  74  247  94
0  3  2  5  4  4  3  4  3
14  12  8  11  8  10  7  10  6
5-14  12  5  13  6  13  6  12  5
15-44  70  14  95  19  107  25  119  26
45-64  27  6  37  8  42  11  67  18
65+  15  9  21  13  23  21  36  3554  Estimates  and Projections  of Mortality  by Cause
Table 34. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Female  Male  Femtal  Male  Female  Male  Female
Sub-Sahara
Total  157  58  215  79  305  109  442  154
0  11  9  14  12  16  13  17  13
1-4  15  13  22  17  26  20  33  24
5-14  19  9  24  11  33  15  43  19
15-44  80  16  111  24  167  37  251  58
45-64  23  5  32  8  45  12  70  19
65+  9  6  12  8  18  13  28  21
MlENA
Total  115  44  154  58  220  77  311  108
0  6  6  9  7  8  6  8  6
1-4  9  8  15  12  16  11  19  13
5-14  13  6  15  6  19  9  23  10
15-44  58  15  78  18  120  28  167  42
45-64  20  5  25  6  38  10  66  17
65+  9  5  12  8  18  12  28  19
Asia
Total  804  301  1304  916  1224  443  1486  560
0  34  31  55  41  26  20  22  16
1-4  75  64  388  298  59  43  52  35
5-14  65  32  106  58  75  35  69  31
15-44  412  90  463  301  629  165  684  179
45-64  153  36  187  112  274  74  415  119
65+  64  48  105  106  161  107  244  181
Othe  CalUes
World
Total  5011  5320  4885  4899  5032  5108  5934  5597
0  1256  1105  1029  819  897  688  746  548
1-4  906  908  805  755  295  243  253  184
5-14  247  239  213  178  188  148  178  133
15-44  477  469  432  414  420  478  433  480
45-64  623  510  589  468  627  570  784  659
65+  1503  2090  1816  2263  2605  2981  3540  3593
Developed
Total  774  1000  913  929  986  976  1229  1086
0  77  31  52  36  18  12  15  9
1-4  71  73  115  115  4  7  4  5
5-14  16  5  9  4  5  2  4  1
15-44  53  27  73  22  30  11  20  7
45-64  114  88  154  78  104  37  113  29
65+  443  778  510  674  826  908  1072  1035
Developing
Total  4238  4320  3972  3970  4046  4132  4705  4511
0  1178  1075  977  783  879  676  731  539
1-4  835  836  690  640  291  236  249  178
5-14  231  234  205  175  183  146  174  132
15-4  424  442  359  393  390  467  413  473
45-64  510  422  435  391  523  534  671  630
65+  1060  1312  1305  1589  1779  2073  2467  2558Annex  B. Supplementary  Tables  55
Table B4. Mortality  rates per 100,000  (continued)
Region  1970  1985  2000  2015
and  age  Male  Female  Maek  Femalk  Male  Female  Male  Female
Indusral
Total  414  483  445  496  609  537  700  521
0  36  14  28  20  5  4  4  2
1-4  59  67  32  38  2  4  1  2
5-14  5  1  2  1  1  0  1  0
15-44  20  10  24  8  6  2  4  1
45-64  54  37  62  32  30  1  35  0
65+  240  354  297  399  565  525  656  515
Nonmarket
Total  359  517  469  433  377  439  529  565
0  42  16  24  17  13  9  11  6
1-4  11  6  83  78  2  3  3  3
5-14  11  3  7  3  4  1  3  1
15-44  32  17  50  14  24  9  17  6
45-64  59  51  92  46  74  35  78  29
65+  204  424  214  276  261  382  417  520
LAC
Total  362  320  426  368  327  292  379  328
0  88  63  95  75  52  40  41  29
1-4  47  41  62  58  18  15  8  6
5-14  18  14  15  10  10  6  7  4
15-44  37  36  33  23  29  21  25  19
45-64  52  40  52  31  46  28  60  32
65+  120  128  170  171  172  183  239  239
Sub-Sahara
Total  712  652  869  766  917  840  1055  947
0  254  206  313  248  316  248  298  225
14  141  120  177  131  130  98  145  92
5-14  66  62  69  62  77  65  85  69
15-44  81  76  96  89  121  113  150  137
45-64  64  56  81  72  96  90  125  110
65+  105  132  133  164  176  225  253  316
AENA
Total  510  490  499  479  459  464  538  537
0  168  151  181  141  136  105  120  89
1-4  68  71  94  89  32  28  30  28
5-14  28  28  27  23  24  19  25  19
15-44  51  51  37  43  51  62  58  71
45-64  61  47  45  43  58  60  83  77
65+  133  141  116  141  159  191  222  253
Asia
Total  2654  2858  2177  2357  2343  2536  2732  2699
0  668  655  389  320  375  283  273  197
1-4  579  603  357  362  111  95  66  53
5-14  119  130  94  80  73  56  57  41
15-44  254  280  194  237  189  272  181  246
45-64  332  278  257  245  324  356  403  411
65+  701  912  887  1113  1271  1474  1752  175156  EelbWe$ and Protai  of MoMt4I1y  by Caus
Table  DS. MmoHtay rats  per 100,000 from specific causes by ape,  sex, and  region,  1985
Regio  and
age group  Makl  Feml  Mal  Female  Mal  Femal  Makl  Femake  Mak  Femakl
Acute respito-
Dioahea  Tliberulodss  qy Infection  Measles  COPD
World
Tota  61  63  21  14  122  108  7  10  43  38
0  1136  962  9  6  1160  966  105  91  288  262
1-4  71  140  6  8  550  365  30  43  9  26
5-14  32  25  2  4  17  24  7  14  2  3
15-44  24  27  16  13  21  28  1  2  3  3
45-64  32  32  55  28  59  52  0  0  53  35
65+  55  60  81  35  376  365  0  0  514  322
Developed
Total  2  2  6  1  37  35  0  0  37  20
0  70  58  1  1  118  91  2  2  13  10
1-4  6  8  1  3  121  90  1  2  3  9
5-14  0  0  0  0  2  1  0  0  0  0
15-44  0  0  4  0  5  1  0  0  2  1
45-64  0  0  10  1  18  5  0  0  29  11
65+  2  2  17  6  254  201  0  0  351  126
Developing
Total  80  84  25  19  148  132  10  13  45  43
0  1316  1115  10  7  1336  1115  122  106  334  305
1-4  83  164  7  9  626  414  35  51  10  29
-14  39  30  2  4  20  28  9  17  3  4
15-4  32  35  20  18  26  37  1  2  4  4
45-64  48  51  77  44  80  80  0  1  65  49
65+  91  118  126  65  462  534  0  1  630  523
Industril
Totd  1  1  2  1  33  38  0  0  43  23
0  5  3  0  0  29  21  0  0  2  1
1-4  2  3  0  1  16  20  1  1  3  3
5-14  0  0  0  0  0  0  0  0  0  0
15-44  0  0  0  0  1  0  0  0  1  0
45-64  0  0  3  1  12  5  0  0  25  11
65+  3  3  17  6  297  251  0  0  378  143
Nonmarket
Total  4  3  11  1  45  29  0  0  27  15
0  164  136  2  1  246  189  5  4  28  22
1-4  11  14  3  5  270  187  2  2  4  18
5-14  0  0  0  0  4  2  0  0  0  0
15-44  0  0  11  0  12  1  0  0  3  1
45-64  0  0  23  1  28  5  0  0  35  10
65+  1  1  18  5  132  96  0  0  272  91
LAC
Total  51  49  15  9  80  63  4  4  31  25
0  931  807  7  5  821  693  45  38  225  213
1-4  71  113  4  5  252  164  19  19  6  19
5-4  13  12  2  2  11  11  2  2  1  2
15-44  12  9  13  9  14  11  0  0  4  3
45-64  32  19  43  16  49  27  0  0  46  24
65+  103  106  75  37  339  330  0  0  411  252Atnae B. Suppknanty  Tablu  57
Table BS. Mortality  rates per 100,000  from specific  causes (continued)
Region  and
age  group  Mal  Femalk  Ma  Femae  Maed Femal  Mak  Femae  Male  Female
Sub-Sahara
Total  272  238  28  24  361  260  38  49  51  49
0  2699  2227  12  13  2280  1869  322  275  624  552
1-4  141  310  11  16  1243  574  86  106  23  54
5-14  146  96  3  10  47  77  36  71  7  11
15-44  169  126  33  25  91  110  4  7  1  1
45-64  223  154  87  55  168  139  0  1  46  40
65+  254  307  129  74  604  684  1  1  544  373
MElNA
Total  122  150  20  20  212  184  18  29  43  42
0  2073  1727  12  10  1m  1465  204  177  478  427
1 4  101  291  8  15  847  538  58  114  16  51
5-14  52  42  3  5  24  34  12  24  3  5
15-44  27  51  20  23  26  50  1  3  5  5
45-64  48  79  62  41  71  83  0  0  53  39
65+  125  241  93  65  460  614  0  1  499  364
Asia
Total  43  49  27  19  111  111  4  6  46  46
0  793  677  10  4  1045  874  56  49  233  215
1-4  65  102  6  6  473  388  18  26  5  18
5-14  18  17  2  3  1s  19  3  6  2  3
15-44  14  21  19  17  18  28  1  1  4  4
45-64  28  37  82  47  74  79  0  1  71  56
65+  67  84  138  68  466  541  0  1  690  605
Jateatal
Polo  Yefow fever  Malria  parasites
World
Totd  1  0  0  0  3  3  0  0  2  3
0  8  3  0  0  44  35  0  0  27  21
1-4  3  2  0  1  4  3  0  0  4  15
5-14  0  0  0  0  2  2  0  0  3  4
15-44  0  0  0  0  1  1  0  0  1  0
45-64  0  0  0  0  3  3  1  0  2  1
65+  0  0  0  0  6  5  2  1  1  1
Developed
Total  0  0  0  0  0  0  0  0  0  0
0  0  0  0  0  0  0  0  0  1  1
1-4  0  1  0  0  0  0  0  0  1  4
5-14  0  0  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0  0  0
Developing
Total  1  1  0  0  4  4  0  0  3  4
0  9  3  0  0  52  41  0  0  31  24
1-4  4  3  0  2  5  3  0  0  5  17
5-14  0  0  0  0  2  2  0  0  4  4
15-44  0  0  0  0  2  2  0  0  1  1
45-64  0  0  0  0  5  4  1  1  3  1
65+.  1  1  0  0  11  10  3  2  1  158  Estiades and Projecwtims  of Mortality  by Cus
Table D5.  Mortality  rates per 100,000  from specific  causes (continued)
Region  and
age  group  Male  Femkle  Male  Female  Male  Femal  Male  Female  Male  Female
Industd
Total  0  0  0  0  0  0  0  0  0  0
0  0  0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0  0  0
Nonmarket
Total  0  0  0  0  0  0  0  0  1  1
0  1  0  0  0  0  0  0  0  2  1
1-4  0  1  0  1  0  0  0  0  2  9
5-14  0  0  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0  0  0
45-6  0  0  0  0  0  0  0  0  1  0
65+  0  0  0  0  0  0  0  0  0  0
LAC
Total  1  0  0  0  1  1  0  0  2  2
0  5  3  0  0  4  5  0  0  15  12
1-4  3  2  0  1  1  1  0  0  4  9
5-14  0  0  0  0  1  1  0  0  1  1
15-44  0  0  0  0  1  1  0  0  0  0
45-64  0  0  0  0  2  1  0  0  2  0
65+  0  0  0  0  3  3  0  0  1  1
Sub-Sahara
Totad  1  1  1  0  5  4  0  0  9  9
0  7  3  0  0  94  69  0  0  56  43
14  2  3  0  2  1  1  0  J  8  20
5-14  0  0  0  0  1  0  0  0  14  12
15-44  0  0  1  0  0  0  0  0  3  2
45-64  0  0  0  0  5  4  1  0  6  2
65+  0  0  0  0  7  7  1  0  1  2
MENA
Total  1  1  0  0  4  4  0  0  4  5
0  6  3  0  0  50  40  0  0  43  33
1-4  2  2  0  1  1  1  0  0  6  16
5-14  0  0  0  0  3  3  0  0  5  5
15-44  0  0  0  0  2  3  1  C  1  1
45-64  0  0  0  0  4  3  1  0  3  1
65+  0  0  0  0  5  6  1  0  1  1
Asia
Totad  1  1  0  0  5  4  1  0  2  3
0  11  3  0  0  48  40  0  0  24  19
1-4  4  3  0  2  8  5  0  0  4  18
5-14  0  0  0  0  2  2  0  0  2  3
15-44  0  0  0  0  2  2  0  0  1  0
45-64  1  0  0  0  6  5  2  1  3  1
65+  1  1  0  0  13  12  4  3  1  1Annex  D. Supplementary  Tables  59
Table B5.  Mortality  rates per 100,000  from specific  causes (continued)
Reglon  and
age  group  Male  Female  Male  Femae  Male  Female  Male  Femak  Mak  Femak
lschemic heart  Cerebrovascular  Otier crdio-  Certain dege-
disease  disease  vascular  Diabetes  erative
World
Total  83  80  66  92  76  78  8  13  29  22
0  2  1  17  13  63  S0  3  4  14  14
1-4  0  0  4  4  13  15  1  1  7  3
5-14  0  0  1  1  6  5  0  0  2  2
15-44  9  3  6  9  13  13  1  2  12  7
45-64  178  71  107  100  111  79  17  25  75  44
65+  1076  1025  957  1080  1009  847  96  122  227  172
Developed
Total  207  208  103  160  118  155  10  17  34  24
0  0  0  3  2  18  14  0  0  5  3
1-4  0  0  1  2  7  12  0  1  2  2
5-14  0  0  0  0  1  1  0  0  0  0
15-44  12  2  4  2  8  4  1  1  7  2
45-64  249  72  87  61  95  50  11  9  64  25
65+  1726  1425  961  1080  1085  1052  87  107  206  129
Developing
Total  45  38  55  69  63  52  7  12  27  22
0  2  2  20  15  70  56  4  5  15  16
1-4  0  0  5  4  14  15  2  1  .8  3
5-14  0  0  2  2  7  6  0  0  2  2
15-44  9  4  6  11  14  16  2  2  13  9
45-64  142  70  117  123  119  96  20  34  80  55
65+  619  614  954  1080  956  635  101  138  242  215
Induswtral
Total  199  174  93  137  122  161  13  21  34  25
0  0  0  4  3  23  17  0  0  6  5
1-4  0  0  2  3  12  19  0  1  2  3
5-14  0  0  0  0  1  0  0  0  0  0
15-44  7  1  3  1  6  2  1  0  4  1
45-64  208  47  55  30  88  37  12  9  54  19
65+  1544  1151  816  910  1022  1062  101  132  205  139
Nonmarket
Total  222  268  122  200  110  144  5  9  36  23
0  0  0  2  1  10  9  0  0  2  1
1-4  0  0  0  0  1  3  0  0  1  0
5-14  0  0  0  0  1  1  0  0  1  0
15-44  21  3  7  4  12  7  1  1  11  4
45-64  325  113  146  110  109  70  9  10  81  35
65+  2246  2007  1375  1441  1265  1032  46  53  208  110
LAC
Total  65  41  43  45  75  76  14  17  31  17
0  1  1  10  6  53  43  1  1  14  12
1-4  0  0  1  2  8  10  0  0  4  2
5-14  0  0  1  1  4  3  0  0  1  1
15-44  8  3  6  6  12  10  2  2  12  5
45-64  179  60  89  72  140  98  41  41  105  41
65+  994  682  727  690  1230  1184  200  232  299  17260  Estimates  and Projections  of Mortality  by Cause
Table B5.  Mortality  rates per 100,000  from specific  causes  (continued)
Region  and
age  group  Male  Female  Mak  Female  Male  Female  Male  Female  Male  Femae
Sub-Sahara
Total  60  35  41  44  73  80  10  15  26  17
0  4  3  42  28  149  111  4  6  22  25
14  0  0  10  5  22  23  0  0  8  2
5-14  0  0  3  3  18  18  0  0  5  4
15-44  16  5  10  11  27  34  3  4  19  12
45-64  243  96  114  122  169  188  38  64  85  53
65+  1129  765  833  813  1193  1131  168  195  239  143
MENA
Total  63  38  40  45  65  n  9  13  23  15
0  3  2  31  19  108  81  3  4  22  22
1-4  0  0  7  5  15  22  0  0  6  2
5-14  0  0  2  2  9  8  0  0  2  2
15-44  11  4  6  9  15  19  2  3  12  8
45-64  222  82  92  102  142  143  31  49  77  44
65+  1128  797  816  821  1167  1134  166  194  240  144
Asia
Total  37  37  62  82  59  40  6  10  27  25
0  1  1  12  11  41  36  5  5  12  12
1-4  0  0  3  4  12  12  3  1  9  5
5-14  0  0  1  1  5  4  0  0  1  2
15-44  7  3  6  12  13  13  1  2  13  9
45-64  115  66  125  134  107  76  14  26  77  59
65+  441  564  1020  1207  860  427  71  109  233  239
Mental  Oral health  Micronutrient
disorders  diseases  disorders  Maintion
world
Total  1  3  0  0  4  7  11  5
0  0  0  0  0  13  10  75  60
1-4  0  0  0  1  4  16  77  22
5-14  0  0  0  0  2  2  2  2
15-44  0  1  0  0  1  4  0  0
45-64  2  1  0  0  5  6  2  0
65+  17  33  0  0  27  26  12  12
Developed
Total  2  5  0  0  3  4  3  1
0  0  0  0  0  2  1  3  1
1-4  0  0  0  1  3  5  38  5
5-14  0  0  0  0  1  0  0  0
15-44  0  0  0  0  1  0  0  0
45-64  1  1  0  0  3  3  1  0
65+  25  38  0  0  21  21  7  7
Developing
Total  1  2  0  0  4  8  13  6
0  0  0  O  0  15  12  87  70
1-4  0  0  0  1  4  18  84  25
5-14  0  0  0  0  3  2  2  2
15-4  1  1  0  0  2  5  0  0
45-64  2  1  0  0  . 5  9  2  0
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Table B5. Mortality  rates per 100,000  from specific  causes  (continued)
Reglon  and
aSe 8P  Mak  Female  Mad  Female  Mak  Female  Mal  Femae
Industrwal
Total  3  6  0  0  2  3  1  1
o  0  0  0  0  1  0  1  0
14  0  0  0  0  3  4  0'  0
5-14  0  0  0  0  0  0  0  0
15-4  0  0  0  0  0  0  0  0
45-64  1  0  0  0  1  1  0  0
65+  29  44  0  0  14  20  5  7
Nonmarket
Totda  2  3  0  0  6  5  8  2
0  0  0  0  0  3  2  7  2
1-4  0  .0  0  3  3  8  90  11
5-14  0  0  0  0  1  0  0  0
15-4  0  0  0  0  2  1  0  0
45-  2  .1  0  0  8  5  2  0
65+  17  25  0  0  42  24  11  7
LAC
Total  1  2  0  1  6  6  6  5
0  0  0  0  0  15  12  85  68
1-4  0  0  0  6  2  3  15  9
5-14  0  0  0  0  3  1  1  1
15-4  0  0  0  0  2  2  0  0
45-64  2  1  0  0  9  9  4  2
65+  11  29  0  0  68  51  36  37
Sub-Sahara
Total  1  1  0  0  9  11  22  8
0  0  0  0  0  22  18  142  108
1-4  0  0  0  0  3  7  87  8
5-14  0  0  0  0  7  7  5  4
15-44  0  0  0  0  5  d  1  1
45-64  3  1  0  0  17  20  5  1
65+  11  26  0  0  73  64  20  27
MENA
Total  I  1  0  0  6  8  13  6
0  0  0  0  0  21  17  134  98
1-4  0  0  0  0  2  6  55  8
5-14  0  0  0  0  4  3  2  3
15-44  0  0  0  0  2  5  0  0
45-64  2  1  0  0  9  15  2  0
65+  11  26  0  0  64  62  V  26
Asia
Total  1  2  0  0  3  7  12  6
0  0  0  0  0  12  9  59  51
1-4  0  0  0  0  4  27  103  36
5-14  0  1  0  0  2  1  1  2
15-44  1  1  0  0  1  5  0  0
45-64  2  1  0  0  3  6  1  0
65+  11  28  0  0  16  21  11  1362  Estimates  and  Projections  of Mortality  by Cause
Table B6. Deaths  in thousands  from specific causes by age, sex, and  region,  1985
Region  and
age  g.oup  Mate  Female  Mak  Femalk  Male  Female  Male  Female  Male  Female
Acute respirato-
Diarrhea  Tuberculosis  ry Infection  Measles  COPD
World
Total  1490  1508  502  342  2970  2579  181  241  1042  901
0  702  569  6  3  717  571  65  54  178  155
1-4  164  310  13  18  1269  807  68  96  20  57
5-14  175  131  10  18  91  122  39  72  12  17
15-44  268  285  179  144  235  306  8  17  35  31
45-64  116  117  197  103  214  191  0  1  190  127
65+  65  95  96  55  444  582  0  0  607  514
Developed
Total  10  10  31  7  212  210  1  1  212  122
0  6  5  0  0  11  8  0  0  1  1
1-4  2  3  0  1  42  30  0  1  1  3
5-14  0.  0  0  0  1  1  0  0  0  0
15-44  0  0  10  0  13  2  0  0  4  1
45-64  0  0  12  1  21  7  0  0  35  14
65+  1  2  8  5  124  163  0  0  171  102
Developing
Total  1480  1498  470  334  2758  2369  180  240  829  779
0  695  564  5  3  706  563  64  54  176  154
1-4  162  307  13  17  1227  777  68  95  19  54
5-14  175  131  10  18  90  121  39  72  12  17
15-44  268  285  169  144  222  304  8  17  30  30
45-64  116  117  185  102  193  184  0  1  155  113
65+  63  93  88  51  320  420  0  0  436  412
Industrial
Total  2  3  9  4  124  148  0  0  159  89
0  0  0  0  0  2  1  0  0  0  0
1-4  0  1  0  0  3  4  0  0  1  1
5-14  0  0  0  0  0  0  0  0  0  0
15-4  0  0  0  0  2  1  0  0  1  1
45-64  0  0  3  1  9  4  0  0  20  9
65+  1  2  6  3  107  138  0  0  136  79
Nonmarket
Total  8  7  22  3  89  62  0  0  54  33
0  6  5  0  0  9  7  0  0  1  1
1-4  2  2  0  1  39  26  0  0  1  2
5-14  0  0  0  0  1  1  0  0  0  0
15-44  0  0  10  0  11  1  0  0  3  1
45-64  0  0  10  1  12  3  0  0  15  5
65+  0  0  2  1  17  25  0  0  34  23
LAC
Total  102  98  31  18  159  127  8  8  63  50
0  54  46  0  0  48  39  3  2  13  12
1-4  15  24  1  1  55  35  4  4  1  4
5-14  6  6  1  1  5  5  1  1  1  1
15-44  11  9  12  8  13  10  0  0  4  3
45-64  8  5  10  4  12  7  0  0  11  6
65+  8  10  6  3  27  31  0  0  33  24Annex B. Supplmentary Tables  63
Table 86. Deaths  In thousands from specific  causes (condnued)
Region  and
age  group  Male  Femal  Male  Female  Male  Female  Mak  Female  Make  Female
Sub-Sahara
Total  613  545  64  55  812  595  85  111  114  113
0  255  208  1  1  216  175  30  26  59  52
1-4  47  102  4  5  411  189  28  35  8  18
5-14  91  59  2  6  29  48  22  44  5  7
15-44  15C  118  31  24  84  104  4  7  1  1
45-64  50  37  19  13  37  33  0  0  10  10
65+  15  21  7  5  35  47  0  0  31  26
MENA
Total  233  274  39  37  407  334  35  52  83  77
0  142  114  1  1  122  97  14  12  33  28
1-4  25  69  2  4  211  127  14  27  4  12
5-14  26  20  1  2  12  16  6  11  2  2
15-44  23  40  17  18  21  39  0  2  4  4
45-64  10  16  13  8  14  17  0  0  11  8
65+  7  15  5  4  27  38  0  0  29  23
Asia
Total  532  580  337  225  1379  1313  52  69  570  540
0  243  196  3  1  321  253  17  14  72  62
1-4  75  112  7  7  550  426  21  29  6  20
5-14  52  47  6  9  44  52  10  16  5  7
15-44  79  118  110  94  104  152  4  8  22  22
45-64  49  60  143  77  129  127  0  1  123  90
65+  33  47  69  38  232  303  0  0  343  339
LUtestlnal
Polio  Ye11ow  fever  Malaria  Schistosomlasis  parasites
World
Total  15  10  4  4  79  67  8  4  60  73
o  5  2  0  0  27  21  0  0  16  12
1-4  7  5  0  3  10  6  0  0  10  34
5-14  1  2  0  0  8  9  0  0  18  18
15-44  0  1  4  0  14  14  3  0  7  5
45-64  1  0  0  0  12  10  3  2  7  3
65+  0  0  0  0  8  8  2  2  1  1
Developed
Total  0  0  0  0  0  0  0  0  1  1
0  0  0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0  0  1
5-14  0  0  0  0  0  0  C  0  0  0
15-44  0  0  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0  0  0
Developing
Total  15  10  4  4  79  67  8  4  59  72
0  5  2  0  0  27  21  0  0  16  12
1-4  7  5  0  3  10  6  0  0  10  32
5-14  1  2  0  0  8  9  0  0  18  18
15-44  0  1  3  0  14  14  3  0  7  5
45-64  1  0  0  0  12  10  3  2  7  3
65+  0  0  0  0  8  8  2  2  1  164  Emate  awd  PVwjtion of Motalty  by  ause
Table 36. Deaths in thousands from specific  causes (continued)
Region  and
age  gronp  MAlk  Fema  Mak  Female  Male  Femal  Male  Female  Mate  Female
Industrial
Total  0  0  0  0  0  0  0  0  0  0
o  o  0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0  0  0
Nonmarket
Total  0  0  0  0  0  0  0  0  1  1
o  o  0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  0  0  0  0  1
5-14  0  0  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0  0  0
45-64  0  0  0  0  0  0  0  0  0  0
65+  0  0  0  0  0  0  0  0  0  0
LAC
Total  1  1  0  0  3  3  0  0  3  4
O  O  0  0  0  0  0  0  0  1  1
1-4  1  0  0  0  0  0  0  0  1  2
5-14  0  0  0  0  1  1  0  0  1  1
15-4  0  0  0  0  1  1  0  0  0  0
45-64  0  0  0  0  1  0  0  0  0  0
65+  0  0  0  0  0  0  0  0  0  0
Sub-Sahara
Total  2  1  1  1  11  9  0  0  21  20
0  1  0  0  0  9  6  0  0  5  4
1-4  1  1  0  1  0  0  0  0  3  7
5-14  0  0  0  0  0  0  0  0  9  7
15-44  0  0  1  0  0  0  0  0  2  2
45-64  0  0  0  0  1  1  0  0  1  0
65+  0  0  0  0  0  0  0  0  0  0
MENA
Total  1  1  0  0  8  7  1  0  8  9
o  0  0  0  0  3  3  0  0  3  2
1-4  1  1  0  0  0  0  0  0  2  4
5-14  0  0  0  0  2  1  0  0  3  2
15-44  0  0  0  0  2  2  0  0  1  1
45-64  0  0  0  0  1  1  0  0  1  0
65+  0  0  0  0  0  0  0  0  0  0
Asia
Total  11  7  2  3  57  48  7  3  26  38
0  3  1  0  0  15  12  0  0  7  5
1-4  5  3  0  2  9  5  0  0  4  20
5-14  1  1  0  0  5  7  0  0  6  8
15-4  0  1  2  0  10  10  2  0  3  3
45-64  1  0  0  0  10  8  3  1  5  2
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Table B6. Deaths In thousands from specific  causes (continued)
Region  and
age  group  Male  Female  Make  Female  Mate  Female  Mal  Female  Mak  Female
Ischemic  heart  Cerebrovascuar  Othr  cadio-  Cerlaln degen-
disease  disease  vascular  Diabetes  exative
World
Total  2019  1929  1608  2205  1838  1867  197  309  700  536
0  1  1  11  8  39  30  2  2  9  8
1-4  1  0  9  9  29  32  3  2  16  7
5-14  1  1  8  7  34  28  1  1  8  9
15-44  105  34  65  95  144  139  16  19  130  78
45-64  642  259  386  365  400  288  62  90  270  160
65+  1270  1634  1129  1722  1191  1350  113  195  268  274
Developed
Total  1173  1254  585  962  669  933  58  100  196  145
0  0  0  0  0  2  1  0  0  0  0
1-4  0  0  0  1  3  4  0  0  1  1
5-14  0  0  0  0  1  0  0  0  0  0
15-44  32  5  11  6  21  10  2  1  17  5
45-64  300  97  105  82  115  67  13  12  77  34
65+  841  1151  468  873  528  851  42  86  100  105
Developing
Total  847  675  1022  1243  1169  934  139  209  504  391
0  1  1  10  7  37  28  2  2  8  8
1-4  1  0  9  8  27  28  3  1  15  6
5-14  1  1  7  7  34  27  1  1  8  8
15-44  73  29  53  89  123  129  14  18  113  72
45-64  342  161  282  283  286  221  49  78  193  127
65+  429  483  661  849  662  500  70  109  167  169
Industrial
Total  733  674  344  529  452  623  48  81  125  95
0  0  0  0  0  1  1  0  0  0  0
14  0  0  0  1  2  4  0  0  0  0
5-14  0  0  0  0  0  0  0  0  0  0
15-44  13  2  5  3  11  3  2  1  8  2
45-64  162  40  43  25  68  31  10  7  43  16
65+  558  633  295  500  369  584  37  73  74  76
Nonmarket
Total  440  580  241  433  217  310  11  20  71  50
0  0  0  0  0  0  0  0  0  0  0
14  0  0  0  0  0  0  0  0  0  0
5-14  0  0  0  0  0  0  0  0  0  0
15-44  19  3  6  4  11  6  1  1  10  3
45-64  138  58  62  56  46  36  4  5  34  18
65+  283  519  173  372  159  267  6  14  26  28
LAC
Total  130  83  86  90  150  153  28  34  62  33
0  0  0  1  0  3  2  0  0  1  1
1-4  0  0  0  0  2  2  0  0  1  0
5-14  0  0  1  0  2  1  0  0  0  1
15-44  7  3  5  5  11  10  2  2  11  5
45-64  43  15  21  18  34  25  10  10  25  10
65+  79  65  58  65  98  112  16  22  24  1666  Estimates  and  Projections  of Mortality  by Cause
Table B6. Deaths  In thousands from specific  causes (continued)
Region  and
age  grvup  Mak  Female  Mal  Female  Mate  Female  Make  Female  Male  Femal
Sub-Sahara
Total  135  81  92  101  164  184  22  34  58  39
0  0  0  4  3  14  10  0  1  2  2
1-4  0  0  3  2  7  8  0  0  3  1
5-14  0  0  2  2  11  11  0  0  3  2
15-44  15  5  9  11  25  32  3  4  18  12
45-64  54  23  25  29  37  45  8  15  19  13
65+  65  52  48  56  69  77  10  13  14  10
MENA
Total  120  70  76  82  125  129  18  25  43  27
0  0  0  2  1  7  5  0  0  1  1
14  0  0  2  1  4  5  0  0  1  0
5-14  0  0  1  1  5  4  0  0  1  1
15-44  9  3  5  7  12  15  1  2  10  6
45-64  45  17  19  21  29  29  6  10  16  9
65+  66  50  48  51  68  71  10  12  14  9
Asia
Total  462  442  768  970  730  468  72  117  340  291
0  0  0  4  3  13  10  1  2  4  3
1-4  0  0  3  5  14  13  3  1  10  5
5-14  0  0  4  4  16  10  0  0  3  4
15-44  42  19  33  66  75  72  8  10  74  49
45-64  200  106  216  215  186  123  25  42  133  95
65+  219  316  508  677  428  239  35  61  116  134
Menal  Oral health  Miomnutrient
disorders  disease  disorders  Malnutrition
World
Total  31  64  0  3  94  158  255  117
0  0  0  0  0  8  6  46  35
1-4  0  0  0  2  8  36  178  48
5-14  1  2  0  0  13  10  8  10
15-44  5  6  0  0  16  41  2  2
45-64  6  3  0  0  17  24  6  1
65+  20  53  0  0  32  42  14  20
Developed
Total  14  32  0  0  19  24  18  8
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  1  2  13  2
5-14  0  0  0  0  1  0  0  0
15-44  0  0  0  0  3  1  0  0
45-64  1  1  0  0  4  3  1  0
65+  12  31  0  0  10  17  3  6
Developing
Total  17  32  0  2  75  135  237  109
0  0  0  0  0  8  6  46  35
1-4  0  0  0  2  7  34  165  47
5-14  1  2  0  0  13  10  8  10
15-44  5  6  0  0  14  40  2  2
45-64  4  2  0  0  13  20  5  1
65+  7  22  0  0  21  25  11  14Annea  B. Supplmenlay  Tabls  67
Table 86. Deaths in thousands from specific  causes (continued)
Region  and
ag group  Mak  Female  Male  Femal  Mal  Femae  Mal  Femae
Industrda
Total  11  25  0  0  7  13  2  4
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  1  1  0  0
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  0  0  0  0
45-64  0  0  0  0  1  1  0  0
65+  10  24  0  0  5  11  2  4
Nonmarket
Total  3  7  0  0  12  11  16  4
0  0  0  0  0  0  0  0  0
1-4  0  0  0  0  0  1  13  2
5-14  0  0  0  0  0  0  0  0
15-44  0  0  0  0  2  1  0  0
45-64  1  0  0  0  3  3  1  0
65+  2  6  0  0  5  6  1  2
LAC
Total  2  3  0  1  12  11  13  11
0  0  0  0  0  1  1  5  4
1-4  0  0  0  1  0  1  3  2
5-14  0  0  0  0  1  1  1  1
15-44  0  0  0  0  2  2  0  0
45;-64  0  0  0  0  2  2  1  0
65+  1  3  0  0  5  5  3  4
Sub-Sahara
Total  2  2  0  0  20  25  49  18
0  0  0  0  0  2  2  13  10
1-4  0  0  0  0  1  2  29  3
5-14  0  0  0  0  4  4  3  2
15-44  0  0  0  0  5  8  1  1
45-64  1  0  0  0  4  5  1  0
65+  1  2  0  0  4  4  1  2
AENA
Total  1  2  0  0  12  15  26  11
0  0  0  0  0  1  1  9  7
1-4  0  0  0  0  1  1  14  2
5-14  0  0  0  0  2  2  1  1
15-44  0  0  0  0  2  4  0  0
45-64  0  0  0  0  2  3  0  0
65+  1  2  0  0  4  4  1  2
Asia
Total  13  25  0  1  32  83  149  69
0  0  0  0  0  4  3  18  15
1-4  0  0  0  0  5  30  120  40
5-14  1  2  0  0  5  4  3  6
15-44  4  6  0  0  5  26  0  1
45-64  3  2  0  0  5  10  2  0
65+  5  16  0  0  8  12  6  768  E8atOim  4nd  Pwjctim  of MOdali  by  QUe
Annex C. Expert  Assessments
This annex provides expert assessments of mortality  in 1985  from some specific
causes by  age, sex, and  region and  explains how  they were obtained. The basic
procedure was to show the regression estimates based on WHO data and regression
models to individual experts on specific  diseases, with a request for corrections and
supporting evidence, and to calculate alternative rates and numbers of deaths on the
basis of plausible recommendations.
Those specific  causes of death on which alternative assessments were made are
discussed in the same order as in preceding tables. Comments were also received on
neoplasms and injury and poison, but no revisions were suggested. For specific  causes
not covered, no comments were received.
Those causes of death left out are not necessarily  less controversial.  For instance,
West and Sommer (1987:4)  estimate 420,000  deaths annually among preschool children
from vitamin A deficiency,  but the regression estimates for deaths under five due to
micronutrient disorders are only 58,000.  More generally, a comparison  in Table  Cl with
figures compiled by Walsh (1988:15)  shows that some estimates in the literature are
considerably higher than the regression estimates here. The comparisons in this table
cannot be examined in  detail because information on  Walsh's  procedures is  not
available. The comparisons do  suggest that  the regression estimates substantially
understate deaths from malaria  and schistosomiasis,  and these discrepancies  are among
those examined below.
Table  Cl.  Comparison  of esdmated  deaths  from certain  specific causes in
developing  countries around  1985 with  Walsh assessment
Ratio:
Walshl  Percent
iRegrv-  Regres-  Regres-
Dise  sion  Walsh  sion  sion  Walsh
Diarrhea  2978  4300  144  30.6  21.9
Tuberculosis  804  900  112  8.3  4.6
Acute respiratory  infection  5127  10000  195  52.6  51.0
Measles  420  2000  476  4.3  102
Polio  25  2  8  0.3  0.0
Yellow  fever, dengue, encephalitis  8  31  388  0.1  0.2
Malaria  146  1500  1027  1.5  7.6
Schistosomnasis,  filarlasis  12  375  3125  0.1  1.9
Pregnancy  218  500  229  2.2  2.5
Malnutrition, micronutrdent  556  2000  360  a  a
Sources: Estimates  reported above and Walsh (1988:15).
'Walsh lists malnutrition  as an associated  cause, with deaths presumed to be also
counted elsewhere. Therefore,  this cause is not included in the calculation  of
percentages.  These percentages  are over  causes included In the table only, not over
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Some expert assessments differ substantially from the  regression esimates.
Consideration of one particular discrepancy-that  for diarrhea in the 65 and over age
group in Latin  America  and the Caribbean-is instructive. The regression  estimate of the
mortality rate was 105  per 100,000,  intermediate among developing countries, and the
expert assessment was that this should be reduced to 10 for each developing country
region. For the reporting countries in Latin America  as a group, the rate is actually 85.
Since these countries have 53 percent of the regional population, even if no one dies
from this cause in the nonreporting countries-e.g.,  Colomia,  Bolivia,  Haiti, Jamaica,
and Nicaragua-a  regional average of 10 is impossible. The regional rate for tiis  age
group, if the data reported to WHO are credited, cannot be lower than 45 per 100,000.
At least four explanations can be advanced for such discrepancies.
First, nonreporting countries may in  fact be so different that  projecting
contrasts among reporting countries does not come close to capturing their variation.
This explanation may suffice  where contrasts are less extreme than in this case, but is
insufficient here. No matter how different the nonreporting countries are assumed to
be, the recommended regional average cannot be attained.
*  Second, the data reported to WHO may be poor, as is certainly the case for
some countries, at least with respect to leaving some causes unspedfied. In this case,
reports  of diarrhea  deaths at  older ages may  also include deaffis for which  the
underlying cause was different.
*  Third, the morbidity surveys on which several of the expert assessments are
based may also be inaccurate: through their focused  nature they may encourage  reports
on  the particular causes being investigated, they may incorporate associated with
underlying causes, they may focus on  such groups as the young with inadequate
attention to others such as the elderly, or they may be somewhat dated and give earlier
rather than current levels.
v  Fourth, case-fatality  rates, when these are used to convert cases to deaths,
may  be problematic.  They often  have a weaker  basis tan  morbidity estimates, may well
be inaccurate, and are generally  broad averages  that fagl  to reflect substantial variability
by age, region, severithr  of disease, and so on. They are also easy to misapply, since
they  may have been calculated to  cover periods other  tan  a year (or without a
reference period at all) or may relate only to hospitalized cases rather than the entire
spectrum of disease, which survey data would attempt to cover.
We cannot assess these possibilities  in every case. However, in giving the expert
assessments below  (Table C2), we do  indicate the  contrasts with  the  regression
estimates and adjust the assessments to be consistent with estimated mortality levels
and in some particulars where they appear dearly too extreme.
Diarrhea
Alternative rates were recommended for the four developing-country regions,
based on a substantial number of country surveys and a report from the U.S.  nstitute70  Estimates  and  Projections  of Mortality  by Cause
Table  C2L.  Expert assessnents  of mortality rates  (per 100,000) and  deaths (in thousands)  for
some specific causes,  by age,  sex, and  region,  1985
Region  and  Rates  Deaths  Rate  Deaths
age  group  A4k  Female  Mak  Femak  Male  Female  Male  Female
Diarrhea  Polio
World
Totd  59  61  1439  1457  1.7  1.5  42  35
0  1582  1342  977  793  19.4  16.9  12  10
1-4  100  193  233  429  12.5  10.8  29  24
5-14  23  20  126  105  0.2  0.2  1  1
15-44  6  9  72  95  0.0  0.0  0  0
45-64  6  7  23  25  0.0  0.0  0  0
65+  6  7  7  11  0.0  0.0  0  0
Developed
Total  2  2  10  10  0.0  0.0  0  0
0  70  58  6  5  0.0  0.0  0  0
14  6  8  2  3  0.0  0.0  0  0
5-14  0  0  0  0  0.0  0.0  0  0
15-44  0  0  0  0  0.0  0.0  0  0
45-64  0  0  0  0  0.0  0.0  0  0
65+  2  2  1  2  0.0  0.0  0  0
Developing
Total  76  80  1429  1447  2.2  1.9  42  35
0  1838  1559  971  788  22.7  19.8  12  10
1-4  117  226  231  426  14.7  12.7  29  24
5-14  28  24  126  105  0.2  0.2  1  1
15-4  8  12  72  95  0.0  0.0  0  0
45-64  9  11  22  25  0.0  0.0  0  0
65+  9  11  6  9  0.0  0.0  0  0
Industrial
Total  1  1  2  3  0.0  0.0  0  0
0  5  3  0  0  0.0  0.0  0  0
1-4  2  3  0  1  0.0  0.0  0  0
5-14  0  0  0  0  0.0  0.0  0  0
15-4  0  0  0  0  0.0  0.0  0  0
45-64  0  0  0  0  0.0  0.0  0  0
65+  3  3  1  2  0.0  0.0  0  0
Nonmarket
Total  4  3  8  7  0.0  0.0  0  0
0  164  136  6  5  0.0  0.0  0  0
1-4  11  14  2  2  0.0  0.0  0  0
5-14  0  0  0  0  0.0  0.0  0  0
15-44  0  0  0  0  0.0  0.0  0  0
45-64  0  0  0  0  0.0  0.0  0  0
65+  1  1  0  0  0.0  0.0  0  0
LAC
Total  77  74  154  148  0.0  0.0  0  0
0  1536  1330  89  75  0.0  0.0  0  0
14  117  185  25  39  0.0  0.0  0  0
5-14  52  48  25  23  0.0  0.0  0  0
154  11  9  10  8  0.0  0.0  0  0
45-6  13  8  3  2  0.0  0.0  0  0
65+  10  10  1  1  0.0  0.0  0  0Reft once  71
Table C2. Expert assessments of mortallty  rates and deafts (continued)
Region  and  Rates  Deaths  Rates  Pelatha
age  group  Male  Femal  Ma  Female  Mak  Femak  Mal  Femtak
Sub-Sahara
Total  217  212  491  489  5.7  5.2  13  12
0  3993  3294  378  308  42.3  42.8  4  4
1-4  206  455  69  151  26.9  24.1  9  8
5-14  48  32  30  20  0.0  0.0  0  0
15-44  11  9  11  8  0.0  0.0  0  0
45-64  12  8  3  2  0.0  0.0  0  0
65+  9  11  1  1  0.0  0.0  0  0
MENA
Total  100  115  192  211  3.1  2.7  6  5
0  2141  1783  147  118  29.1  30.3  2  2
1-4  104  298  26  71  15.9  12.6  4  3
5-14  22  18  11  8  0.0  0.0  0  0
15-44  7  13  6  10  0.0  0.0  0  0
45-64  8,  12  2  3  0.0  0.0  0  0
65+  7  13  0  1  0.0  0.0  0  0
Asia
Total  47  50  592  599  1.8  1.5  23  18
0  1163  993  357  287  19.5  13.8  6  4
1-4  94  149  110  165  13.7  11.8  16  13
5-14  21  19  60  53  0.3  0.4  1  1
15-44  8  12  45  68  0.0  0.0  0  0
45...64  9  11  15  19  0.0  0.0  0  0
65+  9  11  5  6  0.0  0.0  0  0
Yellow  fever, deague  Malri
World
Total  0.5  0.5  13  13  12  10  299  238
0  1.3  1.3  1  1  318  244  197  144
14  1.2  1.3  3  3  7  6  15  13
5-14  1.0  1.1  6  5  3  3  17  13
15-44  0.3  0.3  3  3  2  2  19  24
45-64  0.2  0.2  1  1  10  7  36  27
65+  0.2  0.2  0  0  12  10  15  17
Developed
Total  0.0  0.0  0  0  0  0  0  0
0  0.1  0.1  0  0  0  0  0  0
1-4  0.1  0.1  0  0  0  0  0  0
5-14  0.1  0.1  0  0  0  0  0  0
15-44  0.0  0.0  0  0  0  0  0  0
45-64  0.0  0.0  0  0  0  0  0  0
65+  0.0  0.0  0  0  0  0  0  0
Developing
Total  0.7  0.7  13  13  16  13  299  238
0  1.5  1.5  1  1  372  285  197  144
1-4  1.4  1.5  3  3  8  7  15  13
5-14  1.2  1.2  5  5  4  3  17  13
15-44  0.3  0.4  3  3  2  3  19  24
45-64  0.3  0.3  1  1  15  12  36  27
65+  0.3  0.3  0  0  21  21  15  1772  Etmtes  and  Projedions  of Mortality  by Cause
Table C2. Expert assessments  of mortalit' rates and deafts (continued)
Regio and  Rate  Deoth  Rates  Deaths
a  group  MAde  Femalk  Mak  Femae  Mak  Fcmale  Male  Female
Industrala
Total  0.0  0.0  0  0  0  0  0  0
0  0.0  0.0  0  0  0  0  0  0
1-4  0.0  0.0  0  0  0  0  0  0
5-14  0.0  0.0  0  0  0  0  0  0
15-44  0.0  0.0  0  0  0  0  0  0
45-64  0.0  0.0  0  0  0  0  0  0
65+  0.0  0.0  0  0  0  0  0  0
Nonmarket
Total  0.1  0.1  0  0  0  0  0  0
0  0.1  0.1  0  0  0  0  0  0
1-4  0.1  0.1  0  0  0  0  0  0
5-14  0.1  0.1  0  0  0  0  0  0
15-44  0.1  0.1  0  0  0  0  0  0
45-64  0.1  0.1  0  0  0  0  0  0
65+  0.1  0.1  0  0  0  0  0  0
LAC
Total  0.1  0.1  0  0  3  3  6  5
0  0.1  0.1  0  0  9  9  1  1
1-4  0.1  0.1  0  0  1  1  0  0
5-14  0.1  0.1  0  0  3  2  1  1
15-44  0.1  0.1  0  0  3  3  2  2
s-64  0.1  0.1  0  0  5  2  1  1
65+  0.1  0.1  0  0  5  5  0  0
Sub-Sahara
Total  4.4  4A  10  10  101  77  228  177
0  7.2  7.2  1  1  1882  1386  178  130
1-4  7.2  7.2  2  2  16  20  5  7
5-14  7.2  7.2  4  4  14  6  9  4
i5-44  2.0  2.0  2  2  5  10  5  9
45-64  2.0  2.0  0  0  107  76  24  18
65+  2.0  2.0  0  0  125  130  8  9
MiENA
Total  0.2  0.2  0  0  4  4  8  7
0  0.2  0.2  0  0  50  40  3  3
1-4  0.2  0.2  0  0  1  1  0  0
5-14  0.2  0.2  0  0  3  3  2  1
15-44  0.2  0.2  0  0  2  3  2  2
45-64  0.2  0.2  0  0  4  3  1  1
65+  0.2  0.2  0  0  4  6  0  0
Asia
Total  0.2  0.2  2  2  5  4  57  48
0  0.3  0.3  0  0  48  40  15  12
1-4  0.3  0.3  0  0  8  5  9  5
5-14  0.3  0.3  1  1  2  2  5  7
15-44  0.1  0.1  1  1  2  2  10  10
45-64  0.1  0.1  0  0  6  5  10  8
65+  0.1  0.1  0  0  13  12  7  7R¢61efWs  m73
Table C2. Expert assessments  of mortality  rates and deaths (continued)
Region  and  Rates  Dctdhs  Rates  Deaths
age  group  Male  Female  Male  Femake  Mal  Female  Male  Female
Schistosomfasl  CompHatilons  of pregnancy
World
Total  1.0  0.4  25.4  9.0  20.8  499.5
0  0.0  0.0  0.0  0.0  0.0  0.0
14  0.0  0.0  0.1  0.0  0.0  0.0
5-14  0.1  0.0  0.4  0.2  0.1  0.8
15-44  1.1  0.2  12.1  2.5  45.0  484.8
45-64  2.5  1.0  9.0  3.8  3.8  14.0
65+  3.2  1.5  3.9  2.5  0.0  0.0
Developed
Total  0.0  0.0  0.3  0.0  1.2  7.5
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.0  0.0  0.0  0.0  0.0  0.0
5-14  0.0  0.0  0.0  0.0  0.0  0.0
15-44  0.1.  0.0  0.3  0.0  2.5  6.6
45-64  0.0  0.0  0.0  0.0  0.7  0.9
65+  0.0  0.0  0.0  0.0  0.0  0.0
Developing
Total  1.3  0.5  25.2  9.0  27.3  492.0
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.0  0.0  0.1  0.0  0.0  0.0
5-14  0.1  0.0  0.4  0.2  0.2  0.8
15-44  1.4  0.3  11.9  2.5  58.6  478.2
45-64  3.7  1.6  9.0  3.8  5.6  13.1
65+  5.4  3.1  3.9  2.5  0.0  0.0
Industrlal
Total  0.0  0.0  0.0  0.0  0.1  0.4
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.0  0.0  0.0  0.0  0.0  0.0
5-14  0.0  0.0  0.0  0.0  0.0  0.0
15-44  0.0  0.0  0.0  0.0  0.2  0.4
45-64  0.0  0.0  0.0  0.0  0.0  0.0
65+  0.0  0.0  0.0  0.0  0.0  0.0
Nonmarket
Total  0.1  0.0  0.3  0.0  3.3  7.1
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.0  0.0  0.0  0.0  0.0  0.0
S-14  0.0  0.0  0.0  0.0  0.0  0.0
15-44  0.3  0.0  0.3  0.0  7.0  6.2
45-64  0.0  0.0  0.0  0.0  1.8  0.9
65+  0.0  0.0  0.0  0.0  0.0  0.0
LAC
Total  4.6  0.9  9.3  1.9  16.9  34.0
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.1  0.0  0.0  0.0  0.0  0.0
5-14  0.2  0.1  0.1  0.1  0.2  0.1
15-44  7.0  0.7  6.4  0.6  35.4  32.3
45-64  7.8  2.9  1.9  0.7  6.3  1.6
65+  10.3  4.5  0.9  0.4  0.0  0.074  Eshnales and  Projetions of Mortality  by Cause
Table C2. Expert assessments  of mortality  rates and deaths (contlnued)
Rcion and  Raks  Deaths  Rate  Deaths
age  grmup  Malt  Femal  Male  Femak  Male  Femake  MA  Female
Sub-Sahara
Total  2.4  1.4  5.4  3.3  54.7  126.0
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.1  0.0  0.0  0.0  0.0  0.0
5-14  0.3  0.2  0.2  0.1  0.6  0.4
15-44  0.6  1.3  0.6  1.2  128.6  121.5
45-64  15.2  5.9  3.4  1.4  17.3  4.2
65+  19.5  7.9  1.2  0.6  0.0  0.0
MENA
Total  2.3  0.5  4.4  0.9  20.8  38.0
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.0  0.0  0.0  0.0  0.0  0.0
5-14  0.1  0.0  0.1  0.0  0.2  0.1
15-4  3.7  0.4  3.1  0.3  46.3  36.2
45-64  4.6  1.8  0.9  0.4  8.4  1.7
65+  5.9  2.5  0.4  0.2  0.0  0.0
Asia
Total  0.5  0.2  6.1  2.9  24.8  294.0
0  0.0  0.0  0.0  0.0  0.0  0.0
1-4  0.0  0.0  0.0  0.0  0.0  0.0
5-14  0.0  0.0  0.0  0.0  0.1  0.2
15-44  0.3  0.1  1.8  0.3  52.2  288.2
45-64  1.6  0.8  2.7  1.2  3.4  5.6
65+  3.0  2.3  1.5  1.4  0.0  0.0
Diabebs
World
Total  8  12  188  290
0  3  3  2  2
1-4  1  1  3  2
5-14  0  0  1  1
15-4  1  1  15  16
45-64  16  21  56  78
65+  90  117  110  192
Developed
Total  10  17  58  100
o  0  0  0  0
1-4  0  1  0  0
5-14  0  0  0  0
15-44  1  1  2  1
45-64  11  9  13  12
65+  87  107  42  86
Developing
Total  7  11  130  189
0  3  4  2  2
1-4  2  1  3  1
5-14  0  0  1  1
15-44  2  2  13  14
45-64  18  28  43  65
65+  95  130  68  106Rfrences  75
Table C2. Expert assessments  of mortality rates and deaths  (continued)
Region and  Rates  Deaths
age group  Male  Female  Male  Female
Industrial
Total  13  21  48  81
0  0  0  0  0
1-4  0  1  0  0
5-14  0  0  0  0
15-44  1  0  2  1
45-64  12  9  10  7
65+  101  132  37  73
Nonmarket
Total  5  9  11  20
o  0  0  0  0
1-4  0  0  0  0
5-14  0  0  0  0
15-44  1  1  1  1
45-64  9  10  4  5
65+  46  53  6  14
LAC
Total  14  17  28  34
o  1  1  0  0
1-4  0  0  0  0
5-14  0  0  0  0
15-44  2  2  2  2
45-64  41  41  10  10
65+  200  232  16  22
Sub-Sahara
Total  5  5  10  11
o  o  0  0  0
1-4  0  0  0  0
5-14  0  0  0  0
15-44  2  0  2  0
45-64  10  10  2  2
65+  100  120  6  9
MENA
Total  9  13  18  25
o  3  4  0  0
14  0  0  0  0
5-14  0  0  0  0
15-44  2  3  1  2
45-64  31  49  6  10
65+  166  194  10  12
Asia
Total  6  10  74  119
0  5  5  1  2
1-4  3  1  3  1
5-14  0  0  0  0
15-44  1  2  8  10
45-64  14  26  25  43
65+  71  109  36  6376  Estimates  and  Projections  of Mortality  by Cause
of Medicine (1986:159-162)  for case-fatality  rates. The recommendations  were age- but
niot sex-specific,  with age groups 0 and 1-4 combined. Older ages were separated into
15-59 and 59 and over, but the rates were identical.
The ratios of the rates from the expert assessment to the regression estimates,
by age group and region, were as follows:
Sub-
Saharan
LAC  Africa  MENA  Asia
0-4  1.65  1.48  1.03  1.47
5-14  4.05  0.33  0.43  1.15
15-44  0.95  0.07  0.26  0.58
45-64  0.40  0.05  0.16  0.31
65+  0.10  0.04  0.06  0.14
The inconsistency between the expert assessment for age 65 and over and reported
figures for Latin America  has already been noted. Either the reported deaths are grossly
exc;issive  or the expert assessment for this age group and region is wrong. The 5-14 age
group for Latin America  also presents a problem: the rate for reporting countries is 6.9
per 100,000,  and the expert assessment of 50 could be reached (assuming the reports
are  accurate) only if nonreporting countries have a rate 14 times that of reporting
countries. In general, the pattern of expert assessments across  age groups is so different
from that of the regres'k'n rates that no attempt was made to reconcile  them.
Using the rates from the expert assessment, we calcula*td  deaths within each
age group and allocated these between the sexes (and, in the cc.-. of the youngest age
gr'ups,  between 0 and 1-4) in proportion to numbers of deai' s in  the regression
e.timates.  For all ages  combined, the  regression estimates and expert assessment
actually produce  similar results: the  developing-country mortality rate  is reduced
marginally following  the recommendations  from 62 to 60 per 100,000,  and developing-
country deaths reduced from 3.0 to 2.9 million. However, deaths among those 0-4 are
increased 40 percent and among those 5 and older decreased 63 percent.
Polio
Detailed altemative numbers of deaths were recommended based on lameness
prevalence surveys reported in several publications, including a summary article by
Bernier (1984).  The surveys suggest that new cases worldwide are half a million, and
a case-fatality  rate of 15  percent (the literature suggests rates between 10  and 20  percent)
was applied to obtain the expert assessment.
For industrial market and nonmarket economies  and for Latin America  and the
Caribbean, the recommended figures were uniformly zero. However, some deaths
actually were reported to WHO (e.g., 9 deaths in Sweden in 1985,  and 34 in the United
Kingdom), so that the expert assessment was modified to incorporate the very low
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Adopting  the  recommended rates in  full for the  other  regions leads  to  a
substantial rise in the world mortality rate from polio from .5 to 1.6 per 100,000,  and an
increase in the number of deaths worldwide from 25 to 77 thousand.
The inaease  involves three regions with little data: Sub-Saharan Africa, the
Middle East and North Africa,  and Asia. Recommended  rates at ages 0 and 14,  the age
groups most affected, range from 12 to 43 in these regions. Most of the reported rates
for 1970  (most countries reported some deaths) are at or below the bottom of this range.
For 1985, there  are virtually no useful data-this  cause is missing for all the Latin
American countries due to reporting procedures adopted in the region for TCD-9,  and
includes no  deaths everywhere else except in three countries, for which rates per
100,000  are as follows:
Age 0  Age 14
Korea, Rep. of  15.2  15.9
Sri Lanka  1.3  1.6
Thailand  0.8  0.2
Therefore, reports of deaths to WHO are well below the expert assessments.
Yellow fever,  dengue, and encephalitis
The recommendations  on this category, largely  judgmental, were these: (a)  that
yellow fever deaths in  Sub-Saharan Africa be estimated at 15,000  under age 15 and
5,000  at age 15 and over, out of total numbers of cases of 75,000  and 25,000  respectively;
(b) that deaths in Latin America  and the Caribbean  be estimated at 10 under 15 and 70
at 15 and over, out of total cases of 11,000  and 7,000 respectively;  and (c) that male-
female ratios equal one, and cases at 0 and 14  be proportional to dte size of the age
groups.
The equations for yellow fever were not satisfactory,  and produced an irregular
age pattern (not visible  in preceding tables because rates are so low). The first step in
revision was to smooth the rates, redistributing deaths across age-sex  groups without
altering the total, to give the same rate for all those under 15 and a second rate for all
those 15 and over.
Next, rates were adjusted for Sub-Saharan Africa to give the recommended
number of deaths, which is nine times the regression estimate. A rate of 7.2 per 100,000
for those under  15 resulted. Rates of this order were in fact reported to WHO for
children under five in 1970  (for Portugal and Uruguay);  in 1985,  however, virtually no
deaths from this cause were reported.
Rates for Latin America  were nzt adjusted, because they would have to be lower
than those for developed countries to give the recommended numbers of deaths. The
regression  estimates were intermediate between developed countries, on one hand, and
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Because of the adjustment for Sub-Saharan  Africa,  the world mortality rate rises
from .17 to .54 per 100,000,  and deaths rise from 8,000 to 26,000,  with Sub-Saharan
Africa accounting for 75 percent of the total.
Malaria
Numbers of malaria cases were provided by region, and rough estimates of
deaths for Sub-Saharan Africa and Brazil  were recommended by disease experts. The
prevalence estimates, on the basis of 1985 data reported to WHO, are given below,
together with ratios of the regression estimate of deaths to these cases.
Ratio of deaths
Reported cases  to 1000  cases
Industrial market economies  7,353  10.7
Industrial nonmarket economies  631  12.7
Latin America  and Caribbean  883,451  6.4
Middle East and North Africa  394,969  39.3
Asia  3,560,432  29.5
No 1984 or 1985 Sub-Saharan Africa reports were available, but cases were 4.8 to 7.8
million  annually between 1976  and 1983.  Since  case-fatality  rates may be anywhere from
under  1 to  50 per  thousand,  the  regression estimates of  deaths appear  broadly
consistent with the case reports. The rate for Latin America, though lower than the
others, is consistent with an analysis of deaths in 1977-82  in the Amazon and Center-
Western regions in Brazil, which gave a case-fatality  rate of 5.8 (Fiusa Lima, n.d.).
Nevertheless, an increase was recommended for Latin America, based on an
informal estimate of 6,000  to 10,000  malaria deaths in Amazonia. (Brazil  reports almost
half the cases  in the America  3.) With no more precise  guidance, we simply doubled the
number of deaths in each age-sex group for Latin America, effectively  assuming that
case-fatality  rates are comparable  to those in developed countries. Deaths in Amazonia
would then be 50 to 90 percent of the revised regional total. The resulting age-specific
rates are in the upper range for reporting Latin American countries. At age 0, the
revised rate is 9 per 100,000;  by contrast, the highest reported rates in the region are
El Salvador  7.2 per 100,000
Guatemala  5.7 per 100,000
Ecuador  4.7 per 100,000.
For Sub-Saharan Africa.  estimates of deaths between 405,000  and 952,000  were
recommended.  If 1985 cases were  in  the  range  of  4.8-7.8 million, these  expert
assessments would give deaths per thousand cases  between 50 and 200-ratios that are
probably too high, particularly  if malaria is overall  less lethal in this region than in other
regions. (Malaria is believed to be most lethal among migrants moving into an area
where it is endemic. Lower fatality rates in settled areas of fixed endemicity may be
expected.) We therefore  chose the lower expert assessment of 405 thousand  and
adjusted deaths in each age-sex  group proportionally to reach this total. This implies a
mortality rate 20 times the regression estimate.Annex  C Expet Assessments  79
For the world as a whole, the revised mortality rate rises from the  original
estimate of 3 to 11 and the number of deaths from 146,000  to 537,000,  with 75 percent
of them in Africa.
Schistosomiasis and filariasis
Two sets of age- and sex-specific  morbidity estimates were provided for each
developing country region, one based on Pike (1987:204-205)  and another on Walsh
(1988:15),  and various case-fatality  rates ranging from 2.5 to 5 percent, and averaging
3.5 percent, were recommended.
First we observed that multiplying the average of the morbidity estimates by a
constant case-fatality  rate would produce an age distribution of deaths similar to that
of the regression estimates (though very different in total) only if one assumed a ten-
year lag, i.e., that average duration from initial infection to death is 10 years plus the
average current duration of infection. Making the bold inference from this that those
who die of schistosomiasis  do so on average  ten years after infection, we adopted ratios
of deaths in the current year to current cases  that are a tenth of the recommended case-
fatality rates. (Note that these ratios are not strictly case-fatality  rates, and depend on
complicated assumptions about whether numbers of cases have been rising or falling
and how long a case stays active if death does not occur.)  We did allow these ratios to
vary by region, assumning  a simplified distribution of the three principal species: we
chose a high ratio of .0050  for Asia, assuming Schistosomiasis  japonicum  is more lethal
than other spedes; .0035  for Latin  America  and the Middle East, where S. mansoni  may
have intermediate lethality; and .0025  for Sub-Saharan Africa where S. hamatobium  is
the least lethal. The last parameter is consistent with a reported estimate of a cause-
specific mortality rate of 2 per  thousand  per year among heavily infected men in
Zanzibar (Morrow  n.d.:Table 4). The parameter choices were made to minimize deaths
from this cause. Similarly, we took the lower set of morbidity estimates, based on
Walsh (1988:15),  with the additional argument that the other set used mid-1970s  data.
Total  deaths by region calculated  using these assumptions were distributed among age-
sex groups, using the distribution in the regression estimates.
Even with the choice  of mdnimizing  parameters, the resultng revision raises the
world mortality rate from 0.25 to 0.70 per 100,000  and increases deaths from 12,000  to
34,400.  The revision gives rates for Latin American  males 45-64 of 7.8 per 100,000,  and
for males 65 and over of 10.3. For comparison, the highest reported rates for males in
Latin America and the Caribbean  in 1985  are these:
Age 45-64  Age 65  +
Suriname  4.4  15.9
Guyana  2.2  8.6
No other reporting country in the region has rates dose to these. Even with minimizing
assumptions, therefore, the revised mortality rates are still high in comparison,  with
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The revised Asian rates are lower and more reasonable-and  possibly even too
low, since we estimate Chinese rates per 100,000,  from survey data, at 4.1 for males
45-64 and 9.0 for males 65 and over.
Complications of pregnancy
WHO compiled maternal mortality rates from a variety of sources for around
1983,  and these provide our expert assessment. The compilation is based on
information available  at the headquarters of the World Health Organization-in
the library, in the documentation centres and in the possession of individual
members of the staff. All relevant data bases-e.g.  MEDLINE,  POPLINE-were
searched,  as  were  national  yearbooks,  the  reports  of  consultants,  needs
assessment missions, evaluation studies, etc. Helpful colleagues around  the
world who know of our interest also provided information (WHO 1986:4).
With this type of search, a possible upward bias in the  results, unless a rigorous
standard  of data quality is imposed, cannot be excluded. Such a bias could occur
because of selective reporting of higher (and therefore more 'interesting')  figures,
selective dismissal of reports including no maternal deaths (e.g., because of lack of
evidence whether the category was used), and the utilization of somewhat older data
where nothing else is available. No attempt to minimize this bias is evident in the
report, which in fact goes out of its way to citP-  exceptionally  high figures in a brief
overview.
Mateinal deaths are more commonly  expressed in relation to live births rather
than to population. Reexpressing  the regression  estimates  as a rate per 100,000  livebirths
gives this comparison with the WHO report (where the Middle East and North Afica
region is made up by combining Northern Africa and Western Asia from the WHO
report):
Regression estimates  WHO (1986)
Developing countries  191  450
Latin America and Caribbean  103  270
Sub-Saharan  Africa  229  680
Middle East and North Africa  153  430
Asia  204  420
The WHO (1986)  figures, it should be noted, do not appear to be simple averages of
those collected in  the report. Though they are probably based on  these data,  their
specific derivation is not explained. The differences between these figures and  our
regression estimates are substantial. In mining the WHO report for statistics  to include
in the World Development Report, the World Bank (1988:286)  rejected some of the
higher numbers as inconsistent among 3hemselves,  ending up with reduced average
maternal mortality rates of 329 in low-income economies and 381 in middle-income
economies. A further reduction would be necessary to  agree with  the  regression
estimates, as  well as  with  deaths reported  to  WHO. For Latin America and  the
Caribbean, for instance, reporting countries  have a matemal mortality rate of 75. If thisAnnex C  Expert  Assesments  81
rate is credited, the nonreportng  countries would need a rate of 540-somewhat  too
high  to  accept-to  produce  the  WHO (1986)  figure. Similarly, for Asia, reporting
countries (among which we count China and rural India) have a rate of 202, and a rate
of 1048  would be needed in the nonreporting countries to produce the WHO (1986)
figure.
Adopting the WHO (1986)  estimates, and applying age distributions from the
regression estimates, would raise deaths due to complications  of pregnancy from 218
to 492 thousand in developing countries, an increase of 130  percent.
Diabetes
For diabetes, the recommendations  were essentially subjective: to replace Sub-
Saharan African  rates with rates lower than developed country rates; to reduce Asian
rates to reported levels for Korea, Singapore,  Thailand, and Hong Kong, treating these
as setting an upper bound; to reduce rates for Latin America somewhat; to eliminate
deaths at age 0; and to allow a nominal number of deaths, say 1 in 100,000,  at age 5-14.
The revised African rates were adopted. The Asian rates were not changed
because calculations  subsequent to those provided to the expert had already reduced
them.  Latin American rates were not changed for various reasons, including the
suspicion that there may be higher rates in the Caibbean. Deaths at age 0 were not
eliminated because such deaths were in fact reported. And increasing the rate at 5-14
was not thought necessary  because the regression  estimates  are in fact  nonzero, though
quite small.
The result  of changing the Afdcan rates is to reduce world mortality rates
slightly from 10.5 to 9.9 and deaths from 507,000  to 477,000.
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